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Upon completion of mitosis, the disassembly of spindle components and
reassembly of nuclear structures occur simultaneously around chromatin.
Previous studies have suggested that an important step in this process is the
inactivation of the Aurora B kinase by the Triple A‐ATPase Cdc48/p97, which
physically extracts the protein from chromatin at anaphase. Aurora B is the
catalytic subunit of the Chromosome Passenger Complex (CPC), which promotes
microtubule polymerization and spindle formation from mitotic chromosomes.
Removal of the CPC from chromosomes at anaphase is required for proper
nuclear reassembly, but the molecular basis for this requirement remains unclear.
On the whole, the orchestration of structural events at the end of mitosis is
poorly understood.
Using Xenopus egg extracts, we endeavored to identify uncharacterized
proteins that bind to purified mitotic chromosomes. In doing so we discovered
Vespera, a protein which is functionally antagonistic to the CPC. We show that
Vespera promotes microtubule depolymerization from chromosomes and is
required on chromatin for proper nuclear formation.

We initially identified

Vespera as a protein that is specifically SUMOylated upon interaction with
chromatin, a modification that is dependent on the SUMO E3 ligase, PIASy.
Immunodepletion of Vespera from Xenopus egg extracts interferes with proper
nuclear formation and nuclear transport, and rescue of this defect requires
Vespera SUMOylation. Addition of excess amounts of Vespera to metaphase

extracts disassembles spindle microtubules, and this activity is also dependent
on SUMOylation of Vespera and PIASy. Importantly, the Vespera depletion
defect in nuclear formation can be rescued by nocodazole or by co‐depletion of
the CPC. These manipulations depolymerize microtubules, suggesting that the
microtubule‐depolymerizing activity of SUMO‐Vespera is central to its role in
ensuring proper nuclear formation. Our results suggest that microtubules must
be actively depolymerized around chromosomes to permit proper nuclear
reassembly, a process that is promoted by SUMOylated Vespera.
Ultimately, we would like to understand how various post‐translational
modifications on chromosomal proteins signal events through the cell cycle.
Towards this end, we have developed a chemical method for the identification of
phosphorylation using mass spectrometry, and have applied it to identify novel
phosphorylation sites on Vespera as well as on members of the CPC.
Furthermore, although phosphorylation has been shown to play a central role
during mitosis, we hypothesized that the interplay between phosphorylation and
other covalent modifications may also prove to be important in this context.
Here, we observed that, in the absence of SUMOylated Vespera, protein
phosphatase

1

does

not

fully

accumulate

on

chromosomes

and

dephosphorylation of Aurora B substrates is delayed. The interaction between
protein phosphatases and SUMO may represent an interesting general principal
in

crosstalk

between

covalent

opportunities for future studies.

modifications,

and

provides

intriguing

Ἔσπερε, πάντα φέρων, ὄσα φαίνολις ἔσκέδαςʹ αὔως,
φέρεις οἶν, φέρες αἶγα, φέρεις ἄπυ ματέρι παῖδα.”

Vespera, which brings all things which the gleaming Aurora has scattered,
Brings the sheep, the goats, and the children back to their mother.

‐‐Sappho 104a
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CHAPTER ONE:
GENERAL INTRODUCTION

To divide itself, a cell must perform an intricate choreography that ensures
faithful partitioning of its genetic material, or DNA. In eukaryotic cells,
DNA is loosely packaged by histones and other proteins into chromatin,
which is enclosed by membranes to form the nucleus. In interphase, as the
cell prepares for division, chromatin is replicated inside the nucleus. The
challenge in the ensuing mitotic phase is to divide the replicated chromatin
equally to generate two membrane‐bound nuclei with identical genetic
makeup. To achieve this with maximal accuracy, chromatin is condensed
into tightly packed chromosomes, in which the two copies of replicated
DNA form two resolved sister chromatids.

The sister chromatids are

connected at the centromere of the chromosome, which is also the site of
assembly of the kinetochore, a proteinaceous structure that attaches to
microtubules. This attachment allows sister chromatids to be tethered to
opposite poles of the bipolar metaphase spindle.

Once all the

chromosomes are properly attached to microtubules and aligned in the
middle of the bipolar spindle, the cell proceeds from metaphase to
anaphase, segregating each set of sister chromatids to opposite poles. At
the final stage of nuclear division, telophase, the chromosomes decondense
back to chromatin, and two distinct nuclei can be observed. The end of
mitosis is followed by division of the cytoplasm, known as cytokinesis, to
complete division of the cell into two daughter cells.
Here, we begin by discussing the structural and signaling events of
nuclear division in greater detail. We describe the process of mitosis from
the perspective of the nuclear membrane and bipolar spindle, and provide
1

an overview of the covalent modifications that provide crucial signaling
mechanisms in cell cycle progression. We also discuss events at the end of
mitosis, and the transition back to interphase, which are of particular
relevance to the findings we present. The Aurora B Chromosome Passenger
Complex (CPC) is a central player in events throughout mitosis, and we will
explore the molecular basis of its action.

These discussions serve to

introduce the results described in this thesis, which deal primarily with the
discovery and characterization of Vespera, a protein that we found to be
required for proper spindle disassembly and nuclear re‐formation at the
end of mitosis.

1.1

The phases of mitosis

The process of mitosis was discovered in the 19th century with the advent
of the light microscope. At the time, scientists understood the theory of cell
division, that new cells arise from the division of old cells, but they knew
nothing of the inheritance of genetic material.

The German anatomist

Walther Flemming was the first to document the phases of mitosis, through
beautifully detailed drawings he published in 1882 (Figure 1.1). He coined
the term ʺchromatin,ʺ to describe the dark material he observed as it
condensed, aligned, separated, and decondensed in cells. Thus, Fleming
discovered the chromosome, without possessing an understanding of what
these structures contained. Years later, scientists would begin to make the
connection between the genetic theories put forth by Gregor Mendel in
1865, and the chromosomal structures observed under the microscope, to
develop the chromosomal theory of inheritance (OʹConnor and Miko, 2008).

2

Figure 1.1. Early sketches of cell division, from Zellsubstanz, Kern und
Zelltheilung, Walther Flemming, 1882.

3

We now understand that mitosis is the process by which cells divide
their genetic material, and we divide this phase of the cell cycle into five
parts termed prophase, prometaphase, metaphase, anaphase, and telophase.
During interphase, which precedes mitosis, the genetic material of the cell
exists in a diffuse structure known as chromatin, which is replicated during
the portion of interphase known as S phase.

Once the cell begins the

process of mitosis, it enters prophase, which is characterized by
condensation of chromatin into condensed chromosomes each containing
two partially resolved, duplicated sister chromatids.

The subsequent

prometaphase is characterized in many higher eukaryotes by nuclear
envelope breakdown and movement of chromosomes towards the plane of
cell division.

At metaphase, these chromosomes are attached to

microtubule tethers and align to form a structure termed the bipolar
spindle. Once all chromosomes are properly aligned at the center of the
spindle (the metaphase plate), the spindle elongates, thereby pulling the
two sister chromatids of each chromosome to opposite poles of the spindle.
This phase, in which sister chromatids segregate to opposite sides of the
cell, is termed anaphase. Finally, in telophase, the spindle disassembles,
and segregated chromatids decondense, once again assuming the diffuse
appearance of chromatin (Mitchison and Salmon, 2001).
The fidelity of mitosis relies on several crucial structural features. To
ensure that each daughter cell receives equal genetic material, pairs of sister
chromatids must travel together to the metaphase plate.

Following

replication, sister chromatids are attached by extensive catenation, or
interwining, of their DNA, and ʺglueʺ proteins known as cohesins
(Hopfner, 2003). Sister chromatids must be linked together thus, to ensure
proper sorting of chromosomes, but subsequently, in order to achieve
4

proper segregation at anaphase, they must also be cleanly separated. As the
cell progresses through prophase, motor proteins known as condensins act
to wind chromatin into coiled structures, and topoisomerases decatenate the
tangled DNA structures (Hirano, 2005).

Through this process, sister

chromatids are largely resolved, remaining attached mainly by connection
in one region of the chromosome, known as the centromere.

The

centromere is also the site of assembly of the kinetochore, which makes
essential contributions to the accuracy of mitosis because it serves as the site
for determining proper attachment of microtubules. As chromosomes align
on the metaphase plate, specialized proteins localized to the kinetochore
monitor the attachment of microtubules to ensure that sister chromatids are
attached to opposite poles. This proper configuration of microtubules is
termed amphitelic attachment, in contrast to syntelic attachment, where
both sister chromatids are attached to one pole, or merotelic attachment,
where one sister is attached to both poles (Hauf and Watanabe, 2004).

1.2

Regulation of mitosis

To ensure the orderly progression of cell cycle events, the proteins that
participate are tightly regulated by a complex network of post‐translational
modifications. Predominant among these is phosphorylation, a reversible
covalent attachment of a phosphate group, which is attached and removed
by kinases and phosphatases, respectively. The chief regulators of cell cycle
progression are a group of Cyclin‐dependent kinases (Cdks), which oscillate
in activity through various phases of the cell cycle, dependent on the
availability and association with different cyclin proteins. In organisms
such as budding yeast and fission yeast, the entire cycle is controlled by the
activity of Cdk1, while in multi‐cellular eukaryotes there are two separate
5

Figure 1.2. Control of late mitotic events. Adapted from (Sullivan
and Morgan, 2007). Progression through mitosis is shown by the
cells along the bottom of the figure (chromosomes in blue and
spindle microtubules in black). The transition from metaphase to
anaphase is triggered by an increase in the activity of the
anaphase‐promoting complex (APC) (green line; top of figure), a
ubiquitin‐protein ligase that promotes the assembly of chains of
ubiquitin (Ub) on its substrates, thereby targeting them for
destruction in the proteasome. The main APC targets are securin,
the destruction of which leads to sister‐chromatid separation, and
cyclins, the destruction of which results in a drop in Cdk activity
(blue

line).

Cdk

inactivation

allows

phosphatases

dephosphorylate Cdk substrates during late mitosis.
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to

Cdks that control S‐phase and M‐phase (Morgan, 1997). This Cdk activity is
controlled, in turn, by regulated synthesis and proteolytic destruction of
cyclins. In the Xenopus egg extract system (and other embryonic systems),
high Cdk activity corresponds directly with M‐phase, and its activity is
largely determined by the availability of Cyclin B. This was shown to be the
case by elegant experiments in which destruction of messenger RNA
(mRNA) inhibited cell cycle progression, and addback of only cyclin B
mRNA restored mitotic entry (Murray and Kirschner, 1989; Murray et al.,
1989).
Exit from mitosis is driven by activity of the anaphase‐promoting
complex (APC) which targets M‐phase cyclins and other mitotic substrates
for destruction via the ubiquitin‐proteasome system (Figure 1.2). The APC
also targets the protein securin, releasing the enzyme separase, which
cleaves cohesin proteins to promote sister chromatid separation. Following
the inactivation of Cdk‐cyclin by APC, ordered dephosphorylation of Cdk
substrates by phosphatases orchestrates the completion of mitosis (Sullivan
and Morgan, 2007).

1.3

The Xenopus egg extract system for studying the cell cycle

The early embryo of the African clawed frog Xenopus laevis is a system well‐
suited for cell cycle studies.

Xenopus eggs are very large cells, with a

diameter of 1.3 mm. They are arrested in metaphase of meiosis II, and upon
fertilization, they begin a series of rapid, synchronous divisions.

The egg

contains sufficient stored components for twelve divisions, and therefore
these early cycles proceed in the absence of gene transcription, providing an
excellent system to study the events of interphase and mitosis in relative
isolation from nuclear processes that are not directly related to cell division.

7

Furthermore, pioneering work of Lohka and Masui (Lohka and
Masui, 1983), Lohka and Maller (Lohka and Maller, 1985) and later Murray
and Kirschner (Murray, 1991; Murray et al., 1989) showed that many of the
important functions of the Xenopus early embryo could be reconstituted in

Figure 1.3. Preparation of Xenopus egg extract for cell cycle studies.
Eggs laid by frogs are collected and subjected to a low speed spin to
separate yolk, pigment, and cytoplasmic layers. Cytoplasm is
extracted and utilized as metaphase‐arrested (CSF) extract. Addition
of sperm nuclei and calcium releases the metaphase arrest to allow
interphase nuclear assembly of the sperm nuclei. After completion of
interphase, more CSF extract can be added to induce metaphase and
bipolar spindle formation.

8

vitro using cytoplasmic extracts of frog eggs.

These functions include

sperm nuclear remodeling, DNA synthesis, bipolar spindle formation,
anaphase sister chromatid separation, and nuclear re‐formation. The ability
to study these processes in a test tube has provided many valuable
opportunities to dissect their molecular mechanisms through biochemical
manipulations. Components of the extract can be depleted using affinity
methods, and exogenous components such as recombinant proteins, in vitro‐
translated materials, and small molecules can be added at will.
In a typical experiment, the egg extract is prepared by low‐speed
centrifugation of de‐jellied eggs in buffer containing EGTA (Figure 1.3).
This spin separates yolk, pigment, and cytoplasmic layers, from which the
cytoplasmic extract can be isolated. In the absence of calcium, metaphase
arrest is maintained in these extracts, but can be released by the addition of
calcium to mimic fertilization signaling.

Upon release from metaphase

arrest, Cdk activity is downregulated in the extract, and interphase
processes such as DNA replication and nuclear formation are induced. At
the completion of interphase, the extract can continue cycling to metaphase,
though it is customary to induce metaphase with the addition of more
metaphase extracts that do not contain calcium.

1.4

The nuclear envelope

In eukaryotic cells, the nucleus is enclosed by the nuclear envelope, a
structure that consists of a porous double membrane supported by a
filamentous network known as the lamina (Figure 1.4).

The two

membranes are termed the inner nuclear membrane (INM) and outer
nuclear membrane (ONM). Nuclear pore complexes (NPCs) embedded in
the membrane control the flow of materials in and out of the nuclear
9

compartment.

NPCs permit the free diffusion of small molecules and

regulate the nucleocytoplasmic trafficking of larger molecules by providing
docking sites for a large group of specialized transport molecules (Rout and
Aitchison, 2000).

Figure 1.4. Schematic illustration of the NE. Adapted from (Hetzer et
al., 2005). INM proteins are grouped into Lamin A‐ and Lamin B‐
binding proteins. Many INM proteins contact lamins, and bridge
connections to chromatin via proteins like BAF.

The lamina consists of lamin proteins, intermediate filament‐type
proteins of two types. B‐type lamins are expressed ubiquitously, while A/C‐
type lamins are present only in differentiated cells (Burke and Ellenberg,
2002). The lamin proteins that comprise the lamina interact with integral
membrane proteins as well as chromatin components, thereby helping to
organize intranuclear structure (Gant and Wilson, 1997).

One key

interaction in this arrangement appears to be that between chromatin‐
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binding factor BAF and emerin, which associates with lamina and inner
nuclear membrane.

Thus, chromatin can be tethered to the nuclear

membrane in interphase. Lamin B receptor (LBR) protein and members of
the LAP family of proteins also serve to link lamin and inner nuclear
membrane.

1.5

ʺOpenʺ versus ʺClosedʺ Mitosis

The nuclear envelope provides a useful barrier during interphase, but
during mitosis, the cell must re‐localize tubulin and mitotic regulatory
factors to chromosomes to permit spindle assembly. The so‐called ʺhigher
eukaryotesʺ including plants and animals achieve this through an open
mitosis, in which the nuclear envelope breaks down and the spindle forms
around chromosomes in cytoplasm. In contrast, many single‐celled ʺlower
eukaryotesʺ undergo a closed mitosis in which they retain the nuclear
envelope during nuclear division.

In budding yeast, the spindle forms

between spindle pole bodies that are embedded in nuclear envelope (Sazer,
2005).
Open and closed mitoses present different challenges to the
organisms that employ them. In open mitosis, cells must coordinate nuclear
envelope breakdown and subsequent re‐formation with the other events of
mitosis. We discuss these processes in detail in sections below. In closed
mitosis, cells must distinguish between the very different roles of their
nuclei in interphase versus mitosis, in the context of maintaining the nuclear
compartment. Budding yeast handle this situation by regulating the rate of
import

of

mitotic

regulatory

factors

through

modifications (Hagting et al., 1999; Li et al., 1997)
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post‐translational

It has become clear that rather than partitioning strictly between
open or closed mitosis, many organisms employ intermediate mechanisms

Figure 1.5. The terms ʹopenʹ and ʹclosedʹ mitosis designate extreme cases
of the various ways in which cells handle the NE during mitosis.
Adapted from (Guttinger et al., 2009). (a) In open mitosis, the NE is
completely disassembled and removed from chromatin. (b) In closed
mitosis, the NE stays intact. The establishment of a nuclear spindle
requires nuclear uptake of tubulin. (c) In higher eukaryotes, semi‐closed
mitosis is accomplished by certain cell types, such as in Caenorhabditis
elegans early embryos or during embryonic divisions in Drosophila
melanogaster. The NE finally breaks down during anaphase. (d) Some
lower eukaryotes, such as the filamentous fungus Aspergillus nidulans,
also undergo semi‐closed mitosis and partially disassemble their nuclear
pore complexes to achieve the rapid influx of tubulin.
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to effect the dramatic changes to the nucleus

between interphase and

mitosis (Figure 1.5). The nematode C. elegans displays a partially open
mitosis in which the nuclear envelope disassembles very late, remaining
intact except at spindle poles through early anaphase before fully
disassembling in late anaphase (Lee et al., 2000). In the single‐celled fungus
Aspergillus nidulans, NPC structure changes dramatically in mitosis,
allowing nuclear localization of Ran‐GAP. This protein plays a central role
in regulating nucleocytoplasmic transport, and its re‐localization to the
nucleus results in dramatic changes to that process, giving mitotic proteins
access to chromosomes. Therefore, though A. nidulans undergoes closed
mitosis with nuclear envelope intact, the mitotic reorganization of nuclear
import makes it more closely resemble an open mitosis on the molecular
level (De Souza et al., 2004; De Souza and Osmani, 2007). Clearly, a broad
spectrum of processes have evolved for the division of the nuclear
compartment, and there is much to be learned from studying the diversity
of mechanisms.

1.6

Nuclear envelope breakdown

Two types of mechanisms have been reported to contribute to nuclear
envelope breakdown (NEBD) at the start of open mitosis, but the details
and relative contributions of each is not well understood.

The first is

phosphorylation of nuclear envelope components, likely controlled by Cdk
activity,

that results

in their disassembly.

Lamin proteins

are

phosphorylated during nuclear envelope breakdown (Ward and Kirschner,
1990), and mutation of some of these phosphorylation sites results in failure
to disassemble the lamina in mitosis (Heald and McKeon, 1990)
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Second, microtubules have been proposed to participate in active
tearing of the nuclear envelope (Figure 1.6). This mechanism was proposed
from visualization of the lamina by immunofluorescence of component
proteins and electron microscopy.

Earlier studies showed that

invaginations formed that were occupied by microtubules. Though lamina
disassembly occurs in the absence of microtubules (achieved by treatment
with nocodazole, a microtubule‐depolymerizing drug), it was reported

Figure 1.6.

The role of dynein and MTs in nuclear membrane

dynamics in early mitosis. Adapted from (Salina et al., 2002). NE‐
associated dynein

has been proposed to interact with astral MTs,

pulling NE components toward the centrosome, gradually forming a
deep pocket or invagination. This results in disruption of the NE,
potentially by causing the catastrophic expansion of nuclear
membrane fenestrae created by NPC disassembly.
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to be qualitatively different (Georgatos et al., 1997). More recently, higher
resolution studies have confirmed the presence of asters containing dynein
near the sites of lamina invaginations, and disruption of dynein and
microtubules (again by nocodazole) has the effect of delaying NEBD in
NRK cells (Salina et al., 2002).

Interestingly, it appears that nuclear

envelope pieces are actively removed from chromosomes in a microtubule‐
dependent manner, and transported towards centrosomes (Beaudouin et al.,
2002).

1.7

Nuclear re‐formation
In open mitosis, the disassembly of the nuclear envelope in prophase

necessitates its reassembly in telophase.

Live imaging of fluorescently‐

tagged nuclear envelope proteins has provided clues to the mechanism of
nuclear re‐formation.

Some early studies focused on lamin B receptor,

which was shown to be stable at interphase membranes, but mobile at the
endoplasmic reticulum (ER) in metaphase (Ellenberg et al., 1997) At the end
of mitosis, lamin B receptor is observed to coat decondensing chromosomes,
but favors regions of lower microtubule density, away from areas of spindle
attachment (Chaudhary and Courvalin, 1993; Gerlich et al., 2001).
Subsequent localization studies of other nuclear envelope proteins
confirmed this localization of lamin B receptor, and showed that LAP2B
localizes all over chromosomes.

In contrast, LAP2A, emerin, and BAF

localize to an area termed the ʺcoreʺ region that is near the sites of
microtubule

attachment

(Dechat

et

al.,

2004).

BAF

(barrier‐to‐

autointegration factor) is a DNA‐binding protein and appears to play a
critical role in the recruitment of nuclear membrane proteins to interphase
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chromatin. Live imaging and electron microscopy studies showed that BAF
localizes to the ʺcoreʺ region of anaphase chromosomes before other nuclear
envelope components (Haraguchi et al., 2008), and BAF can recruit LEM
domain‐containing nuclear membrane proteins, like emerin (Haraguchi et
al., 2001). BAF is mitotically phosphorylated by vaccinia‐related kinase
(VRK), causing it to dissociate from chromatin.

This prevents nuclear

envelope assembly during mitosis (Gorjanacz et al., 2007).
The mechanics of nuclear reassembly have been largely studied in
Xenopus egg extracts, beginning in the mid‐1980s when it was found that
Xenopus eggs and their extracts would spontaneously assemble exogenous
DNA into structures resembling nuclei (Forbes et al., 1983; Newmeyer et al.,
1986). These structures recapitulate nuclear functions such as import and
replication. Studies in Xenopus egg extracts have revealed stepwise
assembly of nuclear membranes. Membrane components are targeted to
chromosomes in late anaphase where they form sheets that envelope the
chromatin, and finally expand by nuclear import (Hetzer et al., 2005)
(Figure 1.7). This view has been refined to say that the nuclear envelope
nucleates from intact tubules of mitotic endoplasmic reticulum (ER) which
flatten to enclose the chromatin without fusion (Anderson and Hetzer,
2007). Recent studies have also identified cell cycle‐regulated proteins that
are involved in postmitotic nuclear assembly.

TPX2 is a microtubule‐

associated protein (MAP) that is regulated by RanGTP and promotes
spindle assembly in mitosis, but in interphase it relocalizes to chromatin
where it recruits the inner nuclear membrane protein LAP2 to allow proper
nuclear formation (OʹBrien and Wiese, 2006). The AAA‐ATPase Cdc48/p97
was identified in budding yeast as a protein required for completion of
mitosis (Moir et al., 1982) and had been shown to play roles in assembly of
16

golgi and ER (Meyer, 2005; Uchiyama and Kondo, 2005). NE forms from
ER. It was then shown that formation of
in complex

a closed NE requires p97

with

Figure 1.7. Nuclear envelope reassembly after mitosis. Reproduced from
(Guttinger et al., 2009). (a) The images show HeLa cells with INM green
(stained by GFP‐LAP2β), DNA blue and microtubules red (stained by
RFP‐α‐tubulin). Scale bars, 10 μm. (b) In anaphase, INM proteins are still
dispersed in the tubular mitotic endoplasmic reticulum (ER). During
late anaphase, ER membrane tubules start binding to the chromatin
surface. During telophase, ER tubules are remodeled into flattened
membrane sheets on the chromatin surface. Binding of INM proteins to
DNA/chromatin supports the attachment of membrane sheets to
chromatin. The first traces of lamins can be detected on chromatin at this
stage. NPC formation is completed by the step‐wise recruitment of
further NPC constituents and the nuclear envelope (NE) is sealed.
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Ufd1‐Npl4 (Hetzer et al., 2001). It was thought that p97 acted by inducing
nuclear membrane fusion, but it was later shown that N‐ethylmaleimide
sensitive factor (NSF) may be more important for that (Baur et al., 2007),
and that fusion may in fact not be a primary mechanism for NE formation
(Anderson and Hetzer, 2007).
1.8

Spindle dynamics in mitosis

Remodeling of the nuclear envelope at the start of mitosis generally serves
to allow an influx of tubulin into the nucleus, activating microtubule
polymerization from chromosomes to begin the process of bipolar spindle
formation (Figure 1.8).

In many cells with open mitosis, microtubule

nucleation from centrosomes dominates over that from chromosomes, and
in this case, breakdown of the nuclear envelope is necessary to give
cytoplasmic centrosomes access to the chromosomes. In prophase, these
centrosomes (which had duplicated in S phase) separate and mature,
greatly enhancing their ability to nucleate microtubule polymerization
(Khodjakov and Rieder, 1999).

Centrosomes serve as the poles of the

bipolar spindle, which forms as growing microtubules capture condensed
chromosomes at their kinetochores.

The dynamics of the growing

microtubules are controlled by a variety of stabilizing and destabilizing
proteins, and the microtubule array is organized by various motor proteins.
Working in concert, the activities of these microtubule‐binding proteins
allow the self‐assembly of a bipolar array of microtubules (Gadde and
Heald, 2004; Kline‐Smith and Walczak, 2004).
As the nuclear envelope is re‐forming in telophase, the mitotic
spindle is disassembled. Though it has not been demonstrated, this might
occur via a shift in microtubule dynamics towards depolymerization from
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kinetochores (Kirschner and Mitchison, 1986), as well as through the
increased action of microtubule‐destabilizing proteins such as Op18 and
MCAK, or microtubule‐severing proteins like katanin (Desai and Mitchison,
1997).

Studies in yeast demonstrated that APC destruction of Ase1 is

required for proper timing of spindle disassembly, and non‐destructible
mutant of Ase1 caused a delay in the process (Juang et al., 1997). Similar
phenotypes were reported for mutants in Ipl1 and Sli15, yeast homologs of
Aurora B kinase and its interacting protein, Incenp (Buvelot et al., 2003;
Tanaka et al., 2002). Finally, nuclear envelope re‐formation impedes access
of tubulin to chromatin, reducing the ability of chromatin to nucleate
microtubule polymerization.
As spindle microtubules capture kinetochores, chromosomes move
towards the metaphase plate.

Bi‐oriented attachments, in which sister

chromatids are attached to opposite spindle poles, are stabilized compared
to mono‐oriented attachments. A monitoring system known as the spindle
assembly checkpoint (SAC) signals unattached kinetochores, and prevents
the transition from metaphase to anaphase until all sister kinetochores are
properly attached. One this happens, the cell proceeds to anaphase, with
the spindle elongating and sister chromatids being pulled to opposite poles
(Cheeseman and Desai, 2008).
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Figure 1.8. Chromosome‐spindle interactions in the cell cycle. Adapted
from (Cheeseman and Desai, 2008). During prophase, replicated
interphase chromatin is condensed, while kinetochores assemble on the
centromere regions of chromosomes. After nuclear envelope breakdown
in prometaphase, kinetochores interact with spindle microtubules. By
metaphase, all chromosomes are bi‐oriented and aligned in the middle
of the spindle. During anaphase, separated sister chromatids move away
from each other to opposite spindle poles. Subsequently, during
telophase, the chromatid masses decondense and the nuclear envelope
reforms to generate the daughter nuclei.
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1.9

SUMOylation signaling

This thesis concerns a protein that is specifically SUMOylated on chromatin,
so here we describe this covalent modification in detail.
translational

attachment

of

small

ubiquitin‐like

The post‐

modifier

(SUMO)

polypeptide was discovered in 1996 through investigations of the RanGAP
protein, a critical factor for nucleocytoplasmic transport. The association of
RanGAP with NPCs was found to depend on this post‐translational
modification (Matunis et al., 1996). The SUMO polypeptide is conserved
throughout eukaryotes, and human SUMO‐1 protein can rescue the yeast
deletion (Takahashi et al., 1999). Also conserved is its conjugation system,
which consists of a series of three enzymes, E1, E2, and E3 that hand off the
modification in a cascade culminating in the substrate (Knipscheer et al.,
2008) (Figure 1.9). SUMOylation is a reversible modification whose removal
is catalyzed by a family of isopeptidases (Mukhopadhyay and Dasso, 2007).
The E2 enzyme, Ubc9, is essential in budding yeast, and causes severe
mitotic defects in fission yeast (al‐Khodairy et al., 1995; Seufert et al., 1995).
Mice lacking Ubc9 die at very early embryonic stages, due to inability of
embryonic stem cells to proliferate. When cultured from inner cell mass,
these stem cells exhibit abnormal cell growth, characterized by anaphase
bridges and abnormal nuclear architecture (Nacerddine et al., 2005).
Multicellular eukaryotes contain three isoforms of SUMO termed
SUMO‐1, SUMO‐2, and SUMO‐3. SUMO‐1 is 47% identical to SUMO‐2,
which is 97% identical to SUMO‐3 (Geiss‐Friedlander and Melchior, 2007).
Due to their high degree of similarity, SUMO‐2 and SUMO‐3 are sometimes
collectively referred to as SUMO‐2/3. SUMO‐1 knockout mice display no
phenotype, and it appears that SUMO‐2 can substitute for SUMO‐1 in this
situation

(Zhang et al., 2008; Zhu et al., 2009).
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Though RanGAP is

Figure 1.9. The mechanism of reversible SUMOylation. Adapted from
(Geiss‐Friedlander and Melchior, 2007). Before the first conjugation,
nascent SUMO needs to be proteolytically processed to reveal its C‐
terminal Gly‐Gly motif. This is accomplished by SUMO‐specific
isopeptidases (sentrin‐specific proteases; SENPs). Mature SUMO is
activated by the E1 heterodimer AOS1–BA2 in an ATP‐dependent
reaction, which results in a thioester bond between the C‐terminal Gly
residue and C173 in UBA2. SUMO is then transferred to the catalytic Cys
residue of the E2 enzyme UBC9. Finally, an isopeptide bond is formed
between the C‐terminal Gly residue of SUMO and a Lys residue in the
substrate. This step is usually aided by an E3 ligase. SUMOylated targets
serve as substrates for SENPs, which ensures the reversible and dynamic
nature of SUMOylation.

22

preferentially modified by SUMO‐1 in vivo (Saitoh and Hinchey, 2000), it
has been shown that there is no in vitro preference for attachment of SUMO‐
1 versus SUMO‐2 on RanGAP, but that SUMO‐1‐RanGAP is stabilized
compared to SUMO‐2‐RanGAP by association with Nup358, which protects
it from isopeptidases (Zhu et al., 2009). Unlike Ran‐GAP, the RecQ helicase
BLM shows in vitro preference for modification by SUMO‐2 over SUMO‐1,
and this selectivity is explained by preferential binding of SUMO‐2 to BLM,
compared to SUMO‐1 (Zhu et al., 2008). Post‐translation modification of
SUMO and its conjugating enzymes could also help to explain paralog
selectivity.

Auto‐SUMOylation of UBC9 was found to alter substrate

specificity for certain targets (Knipscheer et al., 2008), and SUMO‐1 is
phosphorylated on a site that can potentially also be modified on SUMO‐3,
but is not present on SUMO‐2 (Matic et al., 2008).
SUMOylation has been attributed to regulation of a diverse
assortment of cellular processes, and seems to serve as an important
signaling module in cells.

Increasingly, SUMO‐interacting proteins are

being identified that contain SUMO‐interaction motifs (SIMs). These motifs
contain a hydrophobic core that may be flanked by acidic residues, though
the complete consensus is not well understood (Hecker et al., 2006). A
recent study has identified proteins that interact with SUMO in affinity
purification, yeast two‐hybrid screen, and yeast synthetic lethal screen
(Makhnevych et al., 2009).

1.10

Role of SUMOylation in the cell cycle

Though many of the details remain unknown, many cell cycle‐related
proteins have been identified to interact with the SUMO pathway
(Makhnevych et al., 2009). Among the best characterized of the mitotic
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substrates is Topoisomerase II (Topo II), an enzyme involved in the
decatenation of DNA loops in sister chromatid resolution at metaphase
(Azuma et al., 2003).

MS analysis of Topo II in Xenopus egg extracts

identified it as a major SUMO substrate on metaphase chromosomes, and
though addition of dominant‐negative Ubc9 (dnUbc) did not affect
decatenation activity, it resulted in chromosome segregation defects that
could be attributed to problems with Topo II. A later study showed that
PIASy is the SUMO E3 ligase required for Topo II SUMOylation, and that
this is the predominant SUMO E3 ligase for substrates on metaphase
chromosomes. Similar to dnUbc9, inhibition of PIASy by antibody addition
resulted in chromosome segregation defects (Azuma et al., 2005). Contrary
to the results in Xenopus egg extracts, a study in mouse demonstrated that
RanBP2 is required for SUMOylation and proper localization of Topo II,
with no apparent requirement for PIASy (Dawlaty et al., 2008).

These

organismal differences, or the interplay between these two different
pathways of Topo II SUMOylation, remain unclear.
In addition to Topo II, the kinetochore‐localized proteins Ndc10,
Cep3, Ndc80, and Bir1 (Survivin in vertebrates) were found to be
SUMOylated in budding yeast. This SUMOylation bears some relationship
to microtubules, as these substrates were de‐SUMOylated upon treatment
of cells with nocodazole (Montpetit et al., 2006). In mammalian cells, the
kinetochore protein CENP‐E was found to be modified by SUMO‐2/3, and
overexpression

of

the

SUMO

isopeptidase

SENP2

resulted

in

mislocalization of CENP‐E. The same study reported that bubR1 and Nuf2
are also modified by SUMO2, but the functions of these modifications
remain unknown (Zhang et al., 2008).
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1.11

The Aurora B Chromosome Passenger Complex

Together with Incenp, Dasra (also known as Borealin), and Survivin, Aurora
B forms a complex known as the Chromosome Passenger Complex (CPC).
This complex derives its name from its pattern of localization during
mitosis (Figure 1.10).

Early in mitosis, the complex associates with

chromatin. In metaphase, it localizes along chromosomes, with enrichment
at inner centromeres. Upon entry into anaphase, the complex re‐localizes
from chromosomes to the spindle midzone, and it is present on the
midbody structure between dividing cells in cytokinesis. The N‐terminal
portions of Incenp and Dasra/Borealin have been shown to associate with
Survivin to form a three‐helix bundle (Jeyaprakash et al., 2007) (Figure 1.11).
It has also been shown that Dasra/Borealin promotes binding of Survivin to
Incenp (Vader et al., 2006).
Aurora B kinase is the catalytic member of the complex, and it
appears that the other members contribute to regulation of its activity.
Dasra/Borealin and Survivin facilitate recruitment of Aurora B to
chromosomal substrates, though the details of their function in the complex
are not well understood. The interaction between Aurora B and Incenp is
important for the activation of Aurora B kinase activity. It has been shown
that phosphorylation of Incenp at three consecutive residues (the ʺTSSʺ
motif) promotes its association with Aurora B, and that this association
enhances the in vitro kinase activity of Aurora B (Bishop and Schumacher,
2002; Honda et al., 2003). Autophosphorylation of Xenopus Aurora B at
Thr248 has also been shown to be an activating mark (Sessa et al., 2005).
Finally, Aurora B is also activated by clustering, which could occur in vivo
as the complex is recruited to chromatin (Kelly et al., 2007).
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Figure 1.10. Chromosomal passenger complex localization during
mitosis. Schematic representation of CPC localization (green) in
mammalian cells during the main phases of mitosis, together with
kinetochores (red), microtubules (teal) and DNA (blue). In prophase
and prometaphase, CPC is found on chromosome arms and starts to
accumulate at centromeres between kinetochores. In metaphase,
chromosomes align on the spindle equator. In anaphase, Aurora‐B
leaves the chromosomes and relocates to the spindle midzone. In
telophase, Aurora‐B concentrates at the midbody between divided
cells.
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Figure 1.11. The Chromosome Passenger Complex Structure.
Structure of a triple‐helical complex of full‐length Survivin with
fragments of INCENP and Borealin/Dasra, adapted from
(Jeyaprakash et al., 2007).

A number of important functions have been attributed to the CPC
during mitosis. Depletion of the complex from Xenopus egg extracts using
anti‐Incenp antibodies results in loss of microtubule polymerization from
chromosomes, and failure to form spindles. Therefore, the CPC is clearly
required in this system for microtubule polymerization from chromosomes.
Loss of CPC function in chromatin‐induced microtubule assembly can be
rescued by co‐depletion of MCAK, a key microtubule‐destabilizing protein
(Sampath et al., 2004).

MCAK negatively regulates microtubules by

promoting catastrophe, or the transition from growth to shrinkage (Walczak
et al., 2002; Walczak et al., 1996).
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The CPC is thought to promote

microtubule polymerization through inhibitory phosphorylation of MCAK
by Aurora B.

Additionally, Aurora B phosphorylates and negatively

regulates Op18/stathmin, another catastrophe‐promoting microtubule‐
destabilizing protein (Gadea and Ruderman, 2005).

Therefore, two

mechanisms by which the CPC promotes microtubule polymerization
involve inhibition of microtubule‐destabilizing proteins.
Budding yeast Aurora B is called Ipl1, and was shown to be required
for release of spindle microtubules from kinetochores (Biggins and Murray,
2001; Biggins et al., 1999; Ruchaud et al., 2007; Tanaka et al., 2002). It was
also known that Aurora B is required in a variety of organisms for proper
chromosome bi‐orientation, leading to the model that Aurora B detects and
detaches improper kinetochore‐microtubule

attachments

(Kelly and

Funabiki, 2009). Proper attachment of sister chromatids to opposite spindle
poles generates tension, and studies have suggested that the mechanism by
which Aurora B recognizes improper attachments is the lack of this tension
(Lampson et al., 2004; Liu et al., 2009). This leads to Aurora B activation of
the spindle checkpoint (Pinsky et al., 2006).
One well‐known mitotic substrate of Aurora B is histone H3 at Ser10
(H3S10ph). Phosphorylation of this site is a hallmark of mitosis, conserved
from budding yeast to human, but the function of this modification is
poorly understood.

Mutation of the residue in the single‐celled ciliate

Tetrahymena thermophila resulted in loss of chromosome condensation and
death due to failures in chromosomes segregation (Wei et al., 1999), but
mutation of the corresponding residue in budding yeast results in no
growth defects (Hsu et al., 2000). The roles of Aurora B and H3S10ph in
mitosis and chromosome condensation remain mysterious.

28

Finally, studies in a variety of organisms have shown that the
essential function of Aurora B and its associated proteins is in cytokinesis
(Adams et al., 2001). Depletion of Aurora B from mammalian cells using
siRNA results in the formation of multinucleate cells. The molecular details
of Aurora B mechanism in cytokinesis are not well understood, but it
appears that Aurora B phosphorylation of cytokinesis substrates including
vimentin and CYK‐4 are crucial for cytokinesis events such as cleavage
furrow formation (Ruchaud et al., 2007).

1.12

Aurora B at the completion of mitosis

In addition to its many mitotic functions, Aurora B is emerging as an
important player in the completion of mitosis. Yeast containing a mutant
form of Ipl1, the yeast homolog of Aurora, were found to exhibit defects in
mitotic spindle disassembly, resulting in a prolonged anaphase (Buvelot et
al., 2003). A further role for aurora B complex in spindle disassembly comes
from the observation that Cdc14 phosphatase targets Sli15 (the yeast
homolog of Incenp), allowing it to relocalize to anaphase spindle
microtubules (Pereira and Schiebel, 2003).
It has been known that the Triple A‐ATPase Cdc48/p97 is critically
important for events at the end of mitosis, and recently it was shown that
the principal target of p97 in promoting nuclear assembly is Aurora B. p97
is a conserved, essential protein that plays roles in a variety of processes,
including endoplasmic reticulum associated degradation (ERAD) of
misfolded proteins (Ye et al., 2003), and activation of transcription factors
NF‐κB, SPT23, and MGA2 (Hoppe et al., 2000).

Mutants in the yeast

protein, Cdc48, lead to mitotic arrest (Moir et al., 1982), due to their inability
to disassemble spindles and re‐form nuclei and Golgi apparatus (Kondo et
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al., 1997; Shorter and Warren, 1999). In Xenopus, it was shown that absence
of p97 function inhibits spindle disassembly, though the mechanism
remains unclear (Cao et al., 2003). Also in Xenopus, the formation of a
closed nuclear envelope requires p97 (Hetzer et al., 2001). The mechanism
of this requirement was revealed when it was found that p97 binds to
ubiquitylated Aurora B and extracts it from chromatin, and that this process
is necessary for proper nuclear formation (Ramadan et al., 2007).
One possible reason that Aurora B must be removed from chromatin
at the end of mitosis is chromatin compaction. Studies of fluorescently‐
labeled chromosomes have shown that chromosomes are maximally
compacted in anaphase, and that this compaction depends on Aurora B
kinase activity (Mora‐Bermudez et al., 2007). Cells that were treated with
hesperadin, a chemical inhibitor of Aurora B, but not inhibitors of Cdk,
showed loss of chromatid compaction. Therefore, Aurora B seems to play a
role in chromosome compaction, which has itself been connected to nuclear
assembly.

Compaction mediated by the DNA‐binding kinesin KID has

been shown to be important for proper nuclear assembly—in the absence of
KID, aberrant multiple small nuclei (multinucleate structures) form (Ohsugi
et al., 2008).
Taken together, the results for p97 show that there is a link between
the postmitotic processes of spindle disassembly and nuclear assembly, and
that the removal of Aurora B from chromatin is central to this process,
possibly through its chromosomal or spindle midzone substrates and a role
for chromatin compaction. One thing that has been overlooked in this
picture, however, is the role of microtubule depolymerization in nuclear
formation. Aurora B complex has a well‐characterized role in promoting
microtubule polymerization from chromosomes (Kelly et al., 2007; Sampath
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et al., 2004), and perhaps this activity presents a major obstacle to proper
nuclear assembly. In the next section, we will briefly introduce the results
of this thesis, which concern the identification of a chromatin‐localized
microtubule destabilizing activity that is required for proper nuclear re‐
formation.

1.13

The role of Vespera in the completion of mitosis
Using

Xenopus

egg

extracts,

we

endeavored

to

identify

uncharacterized proteins that bind to purified mitotic chromosomes. In
doing so we discovered Vespera, a protein which is functionally
antagonistic to the CPC. We chose the name “Vespera,” after the Roman
word for dusk, because this protein appears to oppose some functions of
Aurora, which is the name for the Roman goddess of dawn. We show that
Vespera promotes microtubule depolymerization from chromosomes and is
required on chromatin for proper nuclear formation. We initially identified
Vespera as a protein that is specifically SUMOylated upon interaction with
chromatin, a modification that is dependent on the SUMO E3 ligase, PIASy.
Immunodepletion of Vespera from Xenopus egg extracts interferes with
proper nuclear formation and nuclear transport, and rescue of this defect
requires Vespera SUMOylation. Addition of excess amounts of Vespera to
metaphase extracts disassembles spindle microtubules, and this activity is
also dependent on SUMOylation of Vespera and PIASy. Importantly, the
Vespera depletion defect in nuclear formation can be rescued by nocodazole
or by co‐depletion of the CPC.

These manipulations depolymerize

microtubules, suggesting that the microtubule‐depolymerizing activity of
SUMO‐Vespera is central to its role in ensuring proper nuclear formation.
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Our results suggest that microtubules must be actively depolymerized
around chromosomes to permit proper nuclear reassembly, a process that is
promoted by SUMOylated Vespera.
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CHAPTER TWO: IDENTIFICATION OF VESPERA AND
CHARACTERIZATION OF ITS ROLE IN NUCLEAR FORMATION

2.1

Introduction

In an effort to better understand mitotic processes, we attempt to identify
and characterize novel chromosome‐binding proteins isolated from Xenopus
egg extracts. Our approach relies on the ability to biochemically purify
chromosomes from the extract. In a technique first described by Funabiki
and Murray in 2000, biotin‐dUTP is added to the extract and incorporated
into replicating chromatin. After cycling to metaphase, the biotinylated
chromosomes can then be pelleted out of the extract and purified on
streptavidin‐coated magnetic beads (Funabiki and Murray, 2000).

This

method was later adapted to perform a screen for chromosome‐binding
proteins (Figure 2.1.) that identified Dasra A as a new member of the CPC
(Sampath et al., 2004).
As an alternative to the expression screening strategy, mass
spectrometry (MS) can be used to identify proteins (Figure 2.2).

This

method is made possible by the increasing availability of genome and
cDNA sequence data, which can translated in silico to generate protein
sequence databases. A given protein sample is enzymatically digested by
treatment with proteases, and the masses of the resulting peptides can be
accurately measured by MS. These peptides can be further broken along
peptide bonds using various gas phase chemical reactions, to generate
ladders of fragments differing by discrete amino acids. The peptide and
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Figure 2.1. Schematic of the expression screening method used to
screen

an

arrayed

Xenopus

egg

cDNA

library

for

mitotic

chromosome‐binding proteins. For complete method details, see
(Sampath et al., 2004). Seven thousand bacterial colonies containing
independent cDNA clones were robotically formatted into 96‐well
plates, and plasmid pools were prepared from columns, rows, and
plates. These plasmid pools were added to a coupled transcription‐
translation system to produce labeled protein pools. These pools
were then added to Xenopus egg extracts in interphase, while biotin‐
dUTP was incorporated into replicating chromatin. Following
completion of interphase, extracts were cycled to metaphase as
shown,

and

biotinylated

chromosomes

were

purified

using

streptavidin‐magnetic beads. Chromosome‐associated proteins were
analyzed by SDS‐PAGE and autoradiography, and clones that
showed strong binding to chromosomes were selected for further
analysis.
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fragment masses can then be compared to theoretical values for the entire
protein sequence database, and an identification match can be determined.
This approach to identify proteins using a combination of MS and database

Figure 2.2. Schematic of procedure for identification of proteins
by mass spectrometry (MS).

Proteins are separated by SDS‐

PAGE, and gel slices are excised and subjected to proteolytic
digestion. The resulting peptides are analyzed by MS to obtain
their accurate masses, and by tandem MS (MS‐MS) to determine
fragment masses. Peptide and fragment masses are compared to
theoretical values generated from genome sequence data to
identify proteins.
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searching has revolutionized biochemistry, allowing for the identification of
proteins on a much faster and larger scale than was previously possible
(Cronshaw et al., 2002; Mann et al., 2001; Pandey and Mann, 2000; Tackett et
al., 2005).
We therefore devised a mass spectrometry (MS)‐based proteomics
approach for the identification of chromatin‐binding proteins using Xenopus
egg extracts (Figure 2.3). In order to study bulk chromatin contributions to
large‐scale structures in the cell cycle, we used DNA‐coated magnetic
beads, which are chromatinized in egg extracts and can support formation
of interphase nuclei and mitotic spindles in the absence of centrosomes and
centromeres (Anderson and Hetzer, 2007; Heald et al., 1996). DNA‐beads
were isolated from interphase or metaphase extracts, and the associated
proteins were separated by SDS‐PAGE and identified by MS (see Appendix
I).

Binding to DNA‐beads was confirmed using 35S‐labeled proteins

translated in vitro.

Figure 2.3. Method scheme for the identification of chromatin‐
bead‐binding

proteins.

DNA‐beads

in

interphase

and

metaphase Xenopus egg extracts were purified and analyzed by
MS to identify associated proteins.
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2.2

Identification of Vespera, a Protein SUMOylated upon Binding

Chromatin
Following MS identification of DNA‐beads‐binding proteins, we
singled out hypothetical protein MGC115729 for further study because it
exhibited a prominent mobility shift (~10 kD) upon association with
chromatin (Figure 2.4). In general, we want to understand chromatin‐
induced processes in the cell‐cycle, and therefore a protein with chromatin‐
induced modification was of interest to us. An additional smaller mobility
shift (~2 kD) is observed for in vitro translated protein (Figure 2.4), but not
endogenous protein (see Figure 2.8), and is presumably due to use of an
alternative translation initiation site. This protein, which we term Vespera,
consists of 240 amino acids and contains an N‐terminal SAP motif (after
SAF‐A/B, Acinus and PIAS) (Aravind and Koonin, 2000), which is a
putative DNA‐binding module.
We observed that the chromatin‐dependent mobility shift of Vespera
was consistent in size with posttranslational modification by ubiquitin or
the small ubiquitin‐related modifier SUMO. To identify the modification,
we incubated 35S‐labeled Vespera in CSF (cytostatic factor) extracts arrested
at meiotic metaphase II, supplemented with a large excess amount of
hexahistidine (6His)‐tagged recombinant SUMO‐1, SUMO‐2, SUMO‐3, or
ubiquitin proteins.

All three

isoforms
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of

Figure 2.4 MGC115729 is modified on chromatin. 35S‐labeled, in
vitro‐translated MGC115729 (Vespera) was incubated for 40 min
at 22°C with CSF (metaphase II‐arrested) extract containing
cycloheximide. DNA‐beads or streptavidin‐beads were then
added to the extract for an additional 40 min, after which the
beads

were

purified,

and

analyzed

by

SDS‐PAGE

and

autoradiography. Arrow indicates unmodified protein, and
bracket indicates chromatin‐dependent modification. The double
band is an artefact of in vitro translation in reticulocyte lysates.

SUMO, but not ubiquitin, were conjugated to Vespera, as evidenced by the
additional mobility shift induced by attachment of the His tag (Figure 2.5A).
Furthermore, this Vespera modification is dependent on the SUMO E3
ligase PIASy (Figure 2.5B). From this we conclude that the modification of
Vespera on chromatin is PIASy‐dependent conjugation of SUMO.
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Figure

2.5.

Characterization

Chromatin‐bound,

of

Vespera

SUMOylation.

S‐labeled Vespera was visualized as in
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Figure 2.4, (A) from extracts supplemented with 6His‐SUMO‐1,
6His‐SUMO‐2, 6His‐SUMO‐3, 6His‐Ubiquitin, or buffer control,
and (B) from extracts that were depleted with either control IgG‐
beads or anti‐PIASy beads.

2.3

SUMOylation Site Mapping of Vespera

To determine the site of covalent SUMO attachment, we systematically
mutated each of the thirteen lysine (K) residues in Vespera to arginine (R).
35S‐labeled wild‐type or mutant protein was incubated with DNA‐beads in
CSF extract, and the beads were collected and analyzed by SDS‐PAGE and
autoradiography.

Most

of

the

Vespera

constructs

were

robustly

SUMOylated on chromatin, with two exceptions (Figure 2.6). A K42R
mutant was unable to bind to DNA, and a K230R mutant could bind DNA,
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but was not SUMOylated. K42 corresponds to a highly conserved residue in
the SAP domain that has been shown to make contacts with DNA (Suzuki
et al., 2009), and appears to be strictly required for DNA binding. We
therefore determined that K230 is required for SUMOylation, and is the
apparent attachment site for SUMO chains.

Since the SUMOylation site

Figure 2.6. Mapping of Vespera SUMOylation site. Wild‐type
Vespera and thirteen Lys to Arg mutants were analyzed as in
Figure 2.4. Top gel: Chromatin‐bound Vespera proteins. Bottom
gel: in put, in vitro‐translated Vespera proteins. deficient K230R

mutant can bind DNA, SUMOylation is not required for targeting
Vespera to chromosomes.
Finally, we asked if SUMOylation of Vespera is cell‐cycle dependent.
We prepared chromatin beads that were incubated in CSF extracts, or CSF
extracts released with calcium. Vespera SUMOylation occurred in both
cases (Figure 2.7), so we conclude that Vespera SUMOylation on chromatin
beads is not cell‐cycle dependent.
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Figure 2.7 Vespera SUMOylation is not cell cycle‐dependent. Wild‐
type or mutant Vespera was analyzed as in Figure 2.2. 35S‐labeled
Vespera was incubated with metaphase CSF extracts (M), or
interphase extracts (I). Phosphorylated Vespera is marked with an
asterisk (*).

2.4

Vespera Is Required for Proper Interphase Nuclear Formation

In order to study native Vespera, we raised polyclonal antibodies to the full‐
length recombinant protein. In Western blots of CSF extracts, these
antibodies recognized one principal band corresponding to the molecular
weight of Vespera, ~32 kD (Figure 2.8). Immunoprecipitation and MS
analysis confirmed that these antibodies bind endogenous Vespera (Figure
2.9). Furthermore, native Vespera SUMOylation could be detected by
Western blotting by adding high concentrations of DNA to egg extracts
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Figure 2.8. Detecting DNA‐induced SUMOylation of endogenous
Vespera. CSF extracts were incubated with increasing amounts of
plasmid DNA (0, 20, 50, 100, 200 μg/ml) for one hour at 22°C.
Total extract proteins are analyzed by Western blotting with anti‐
Vespera antibodies.

(Figure 2.8). Immunolocalization showed that Vespera binds throughout
chromatin in interphase nuclei (Figure 2.10A) and all along chromosomes
on metaphase spindles (Figures 2.10B and C).
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Figure 2.9.

MS validation of anti‐Vespera antibodies

recognition of Vespera. CSF extracts were incubated with anti‐
Vespera beads for 30 min on ice. Beads were collected and
washed, and the immunoprecipitated proteins were digested
with trypsin (7h, 37°C). Tryptic peptides were collected using
C18 resin and analyzed by MS and MS/MS. Listed in the table
are the Vespera peptides confirmed by MS/MS, with MS/MS
spectrum shown for one of these peptides.
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Figure 2.10. Immunofluorescence localization of Vespera. (A)
Interphase localization of Vespera. Sperm nuclei were added to
CSF extract, then cycled to interphase by addition of calcium for
80 min at 22°C. DNA was stained with Hoechst 33258, and
Vespera was visualized by indirect immunofluorescence. Scale
bar, 5 μm. (B) Immunolocalization of Vespera on metaphase
spindles assembled on replicated chromosomes. Scale bar, 20 μm.
(C) Immunolocalization of Vespera on an individual metaphase
chromosome in diluted extracts. Scale bar, 10 μm.

We then sought to ascertain the function of Vespera and its
modifications by immunodepletion of the native protein from CSF extracts
and replacement with wild‐type or mutant recombinant proteins (Figure
2.11).
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Figure 2.11. Immunodepletion and addback of Vespera. (A) CSF
extracts containing cycloheximide were depleted with either control
IgG‐beads (lane 1) or anti‐Vespera beads (lanes 2‐6). In lanes 3‐6, the
indicated recombinant Vespera proteins were added to extracts
following depletion. Total protein samples were collected and
probed by Western blot using anti‐Vespera antibodies. (B)
Recombinant Flag‐tagged wild‐type and mutant Vespera proteins
were analyzed by SDS‐PAGE and Coomassie stain. See Materials
and Methods for bacterial expression and purification methods.

Demembranated sperm nuclei were added to these extracts, followed
immediately by addition of calcium, which mimics fertilization signaling to
release extracts from metaphase to interphase. In mock‐depleted interphase
extracts, round nuclei formed around sperm chromatin within 30 min of
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Figure 2.12. Timecourse analysis of nuclear formation. Sperm nuclei
and calcium were added to depleted extracts shown in (A) at 22°C to
induce assembly of nuclei. DNA was stained with Hoechst 33258.
Scale bar, 10 μm (C) Quantitation of normal and abnormal nuclear
formation in (B). Values shown are the mean and standard deviation
from three independent experiments, with ~200 nuclei counted per
sample per experiment.

sperm addition and decondensed further over time in a uniform manner.
By contrast, sperm chromatin in Vespera‐depleted (∆Vespera) extracts gave
rise to deformed, pinched nuclei that swelled irregularly (Figure 2.12A).
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This

phenotype

was

rescued

by

adding

wild‐type

or

S183A

(phosphorylation) mutant protein, but not K42R (DNA‐binding) or K230R
(SUMOylation) mutant proteins (Figures 2.12A and B). These results
suggest that Vespera functions in interphase nuclear assembly, and that this
role requires its DNA binding activity as well as its modification by
SUMOylation. The defect is not due to impairment in release from
metaphase arrest, as the metaphase‐dependent phosphorylation of histone
H3 at threonine 3 (H3T3ph) was properly removed upon induction of
interphase in ∆Vespera extracts (Figure 2.13A). Overall chromosomal
SUMOylation did not appear to be affected in ∆Vespera extracts (Figure
2.13B). Despite the morphological defects,
extracts appears able to recruit nuclear

the chromatin in ∆Vespera

membrane components (Figure

2.14C), as visualized by immunofluorescence staining of lamin B3
(Shumaker et al., 2008) and nucleoporins (Davis and Blobel, 1986).
Nuclear function, however, is defective, as deformed nuclei in
∆Vespera extracts exhibit impaired import of green fluorescent protein
(GFP) tagged with an SV40 nuclear localization signal (GFP‐NLS, Figure
2.14). The defect we observe may encompass two activities of the extract: 1)
sperm chromosome remodeling and 2) interphase nuclear assembly. The
first is an egg‐specific process whereby, upon fertilization, the highly
compact sperm chromatin, devoid of histone H2A and H2B, is remodeled to
a more relaxed structure containing nucleosomes (Wright, 1999).

The

second is a general process in open mitosis—nuclear envelope disassembly
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Figure 2.13. Characterization of Vespera Depletion. (A) Depleted extracts
(Control, ∆Vespera, and ∆Vespera with wild‐type addback) were probed by
Western blot for anti‐H3T3ph at 0 min and 20 min following the addition of
calcium. (B) Vespera depletion does not affect global chromatin‐induced
SUMOylation.

Plasmid DNA was added to control (IgG‐depleted),

Vespera‐depleted, and PIASy‐depleted extract, to a final concentration of
200 μg/ml. 0.5 ml of extract was analyzed by SDS‐PAGE and Western blot
using antibodies against SUMO‐2/3. (C) Interphase nuclei were assembled
for 60 min in the indicated extracts, and DNA was stained with Hoechst
33258, and Lamin B and nucleoporins were visualized by indirect
immunofluorescence with anti‐xLB3 and mAb414, respectively. Scale bar,
10μm.
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Figure 2.14. Nuclear Import is Impaired in ∆Vespera Extracts.
Nuclei were assembled in control and Vespera‐depleted extracts
containing GST‐GFP‐NLS, and visualized at the indicated
timepoints. DNA was stained with Hoechst 33258. Scale bar, 10
μm.

in prophase must be followed by reassembly at the return to interphase. In
addition, nuclear reassembly is important for sperm pronuclear formation
at fertilization. To better understand the role of Vespera in these two
processes, we decoupled them by preincubating compact sperm nuclei in
CSF extracts for 45 minutes prior to addition of calcium. This allows time
for sperm remodeling to occur prior to calcium‐induced release from
metaphase arrest. In this case, control and ∆Vespera extracts both produced
condensed, remodeled chromosomes from sperm, but ∆Vespera extracts
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remained deficient in interphase nuclear formation (Figure 2.15). Therefore,
we conclude that Vespera is not required for sperm chromosome
remodeling, but is required for nuclear re‐formation.

Figure 2.15.

Vespera‐depleted egg extracts exhibit defective

nuclear assembly around remodeled sperm chromatin.

CSF

extracts were depleted with control IgG‐beads or anti‐Vespera
beads, then incubated with sperm (2000/μl) for 45 min at 22°C.
Calcium was then added to induce interphase, and DNA was
visualized by Hoechst dye after 70 min.

2.5

Excess Vespera Inhibits Metaphase Spindle Assembly

As a further clue to Vespera function, we observed that excess Vespera
protein disrupted bipolar spindle formation in metaphase extracts. We
added 10‐fold excess recombinant wild‐type or mutant Vespera proteins to
extracts (Figure 2.16A) and monitored spindle assembly on replicated
sperm chromosomes. Interphase proceeded normally in all cases (data not
shown), but 50 min after induction into metaphase, we found that extracts
containing excess wild‐type Vespera did not form spindles and exhibited
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greatly reduced microtubule polymerization from chromosomes. Addition
of mutant Vespera that is unable to bind DNA (K42R) or non‐
SUMOylatable Vespera (K230R) had no effect (Figures 2.16B and 2.16C).
Note that non‐SUMOylatable Vespera is still able to bind DNA (Figure 2.6)
so these results do not reflect a nonspecific effect of excess proteins on
DNA.

Figure 2.16. Effect of excess Vespera in control egg extracts. (A) CSF
extracts were supplemented with excess (4.5 µM) wild-type or mutant
Vespera, or buffer (control), as indicated. Total protein samples were
collected and probed by Western blot using anti-Vespera or anti-Xkid
antibodies (Funabiki and Murray, 2000). (B) Sperm nuclei were added
to extracts shown in (A) and cycled through interphase to metaphase.
Chromosomes were visualized with Hoechst 33258 (blue), and
microtubules with rhodamine-tubulin (red). Scale bar, 10µm. (C)
Quantitation of structures observed in (B). Values shown are the mean
and standard deviation from three independent experiments, with >150
chromosomal structures counted per sample per experiment.
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Having seen that nonSUMOylatable Vespera is unable to disrupt
spindle formation, we next asked if the spindle‐disruption activity of
Vespera indeed acts through its SUMOylation. We repeated the excess
Vespera addition experiment, this time in PIASy‐depleted extracts where
Vespera SUMOylation is inhibited (Figure 2.17A). Unexpectedly, without
addition of Vespera, bipolar spindles form but their size was smaller in the
absence of PIASy (Figure 2.17B, top)—there seems to be a PIASy target that
promotes microtubule assembly. As predicted, however, excess wild‐type
Vespera protein was unable to disrupt spindle assembly in PIASy‐depleted

Figure 2.17. Effect of excess Vespera in ∆PIASy extracts. (A) CSF
extracts were depleted with control IgG‐beads or anti‐PIASy beads,
then supplemented with excess wild‐type or mutant Vespera, or
buffer, as indicated. Total protein samples were probed by Western
blot using anti‐PIASy or anti‐Vespera antibodies. (B) Sperm nuclei
were added to extracts shown in (A) and cycled through interphase
to metaphase. Representative structures are shown, with DNA
visualized by Hoechst 33258 (blue) and microtubules by rhodamine‐
tubulin (red). Scale bar, 10 μm.
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extracts (Figure 2.17B). Therefore, we conclude that the mechanism by
which excess Vespera disrupts spindle formation requires its SUMOylation.

2.6

Vespera‐Depletion Stimulates Microtubule Assembly in Metaphase

Extracts
The negative effect of excess Vespera on spindle formation suggested a role
in microtubule destabilization. To examine if endogenous Vespera executes
this function, we monitored aster formation in control and ∆Vespera
extracts. We visualized asters growing from sperm centrosomes 12 min
after sperm addition to CSF extracts at 20°C, and found that Vespera‐
depleted aster microtubules were more dense than control asters (Figure
2.18A and 2.18B). This suggests that microtubule polymerization is
increased in ∆Vespera extracts, compared to control. Consistent with the
requirement of sperm chromosomes for Vespera activation in this process,
Vespera SUMOylation can be observed within 10 min after adding sperm
nuclei (Figure 2.18C). We conclude that chromatin‐bound, SUMOylated
Vespera has a destabilizing effect on metaphase microtubules.
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Figure 2.18. Microtubule polymerization from sperm centrosomes is
increased in Vespera‐depleted egg extracts. (A) Sperm aster visualization.
Extracts containing cycloheximide were depleted with control IgG‐beads
or anti‐Vespera beads.

Vespera‐depleted extracts were supplemented

with buffer or wild‐type Vespera, as indicated. Sperm nuclei (500/μl) and
calcium were added to the extracts and incubated for 12 min at 20°C.
DNA was stained with Hoechst dye and microtubules were visualized by
rhodamine‐tubulin. (B) Quantitation of integrated rhodamine‐tubulin
fluorescence intensity from samples in (A). Values represent mean and
standard deviation for 50 asters per sample. For each aster, a background
measurement from a region of equal dimensions was subtracted from the
intensity value. (C) Timecourse analysis of Vespera SUMOylation. Sperm
nuclei (10,000/µl) were added to CSF extract, and total protein samples
were analyzed at the indicated timepoints by western blot using anti‐
Vespera antibodies.
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2.7

Nocodazole Bypasses the Requirement for Vespera in Nuclear

Formation
Having seen that Vespera exhibits microtubule‐destabilizing effects, and
that it is required for proper nuclear assembly, we asked if these two
phenotypes might be related. We hypothesized that reduced microtubule
disassembly activity might be the cause of deformed nuclei in ∆Vespera
extracts. To test this hypothesis, we examined if a microtubule‐destabilizing
drug, nocodazole, can rescue the deficiency of functional nuclear formation
in ∆Vespera extracts. ∆Vespera CSF extracts containing sperm nuclei were
released into interphase in the presence or absence of nocodazole. As
described above, Vespera depletion resulted in deformed interphase nuclei.
Addition of nocodazole, however, was able to restore the deformed nuclei
to a round, normal shape in ∆Vespera extracts (Figures 2.19A and 2.19B).
This suggested that the interphase Vespera‐depletion phenotype may
indeed be caused by reduced microtubule depolymerization activity.
We sought to determine if this apparent rescue of interphase
morphology reflects restoration of functional nuclei by examining nuclear
import. When sperm nuclei were added to control extracts at 18°C,
enrichment of GFP‐NLS inside nuclei was visible after 30 min, and
nocodazole addition did not impair the nuclear accumulation of GFP‐NLS.
Chromatin became condensed at a later time point (60 min) in the presence
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Figure 2.19. Nocodazole can bypass the requirement of Vespera in
nuclear formation. (A) Sperm nuclei were assembled for 60 min at
22°C in control extracts, or ∆Vespera extracts with or without 5 μg/ml
nocodazole. DNA was stained with Hoechst 33258. Scale bar, 10 μm.
(B) Quantitation of structures observed in (A). Values shown are the
mean and standard deviation from three independent experiments,
with >200 nuclei counted per sample per experiment. (C) Timecourse
analysis of nuclear import in control and Vespera‐depleted extracts,
with or without nocodazole. Nuclei were assembled in the indicated
extracts, with chromatin visualized by Hoechst 33258, and nuclear
import monitored by GFP‐NLS.
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of nocodazole, but nuclei retained proper size and shape. For ∆Vespera
extracts, the nuclear morphological defect correlated with impaired import,
and only some regions of the nuclei showed accumulation of fluorescence
after 60 min. Strikingly, nocodazole addition was able to completely rescue
this import defect (Figure 2.19C). It appears that Vespera is required to
ensure both the uniformly round shape of nuclei and their proper function
as a cellular compartment through microtubule destabilization.

2.8

Discussion

In conclusion, we identified a new chromatin‐binding protein, Vespera, that
is required for proper nuclear re‐formation. Vespera displays microtubule
destabilizing activity, and we therefore postulate that, at the end of mitosis,
microtubules must be disassembled around chromosomes to permit nuclear
envelope re‐formation. Vespera also represents a novel chromatin‐localized
microtubule destabilizing activity.

Further evidence that the essential

requirement of Vespera in nuclear re‐formation is based in its negative
effect on microtubules comes from our observation that the microtubule‐
depolymerizing drug nocodazole can rescue the nuclear defect associated
with Vespera depletion.
How could microtubules interfere with nuclear assembly? Nuclear
envelope formation is mediated by proteins that bridge chromatin and
components of the lamina or nuclear membrane (Guttinger et al., 2009). It is
thought that lamin B receptor (LBR) and other DNA‐binding proteins
contribute to this process. Early observations of nuclear formation in HeLa
cells noted that binding of LBR to chromosomes appeared to favor regions
of lower microtubule density (Chaudhary and Courvalin, 1993). More
recently, electron microscopy studies have demonstrated that continuous
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stretches of new membrane are interrupted by gaps occupied by anaphase
microtubules contacting chromosomes (Haraguchi et al., 2008). These
observations suggest that the interaction between spindle microtubules and
chromosomes may physically obstruct nuclear membrane attachment, or be
otherwise refractory to the assembly of nuclear membrane components
around chromatin. Since microtubules are known to play a mechanical role
in nuclear envelope breakdown at the start of mitosis, they may
correspondingly interfere with timely and efficient nuclear envelope
assembly at the end of mitosis.

58

CHAPTER THREE: VESPERA IS FUNCTIONALLY
ANTAGONISTIC TO AURORA B

3.1

Introduction

Our results from Chapter Two indicate that Vespera has a positive effect on
interphase nuclear assembly, and a negative effect on metaphase
microtubule polymerization. We noted that the opposite functions have
been attributed to the Aurora B kinase, a member of the CPC (Figure 3.1).
Excess Aurora B has been shown to disrupt interphase nucleus formation
(Ramadan et al., 2007). Depletion of the Aurora B complex has been shown
to be required for metaphase spindle assembly in Xenopus egg extracts
(Sampath et al., 2004). Recall that excess Vespera results in failure to form
metaphase spindles, while depletion of Vespera disrupts the formation of
interphase nuclei.
Several pieces of evidence hint that the CPC plays a central role in
the events at the end of mitosis. It has been previously shown that
metaphase

chromosomes

activate

the

Aurora

B

pathway

(while

phosphatases suppress it in the cytoplasm), and that this local activation
promotes

microtubule

assembly

from

chromosomes

through

the

inactivation of the microtubule depolymerizing factors MCAK and Op18
(Gadea and Ruderman, 2005; Kelly et al., 2007; Sampath et al., 2004). The
CPC associates with chromosomes in metaphase, but relocalizes to the
spindle midzone in anaphase (Ruchaud et al., 2007). Aurora B removal
from chromosomes is effected by the AAA‐ATPase Cdc48/p97, an event that
was found to be critical for proper nuclear formation (Ramadan et al., 2007).
This discovery helped to explain previous observations that Cdc48/p97 is
required to form a closed nuclear envelope (Hetzer et al., 2001).
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Figure 3.1. Vespera and Aurora B exhibit antagonistic functions. In
Chapter Two we provided evidence that Vespera inhibits spindle
formation and promotes nuclear formation. The opposite functions
have previously been attributed to Aurora B.

In this chapter, we describe our observations that co‐depletion of
Vespera and Aurora B can complement one another. Furthermore, full
chromosomal

enrichment

antagonizes

Aurora

B,

of

protein
requires

phosphatase
SUMOylated

1

(PP1),
Vespera,

which
and

dephosphorylation of Aurora B substrates is attenuated in the absence of
Vespera.
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3.2

Vespera and Aurora B Co‐Depletion Can Suppress the Defects of

Individual Depletions

We asked if Vespera and Aurora B deficiencies can complement one
another. While immunodepletion of the CPC results in failure to polymerize
microtubules from metaphase chromosomes (Sampath et al., 2004), bipolar
spindles can form in ∆Vespera extracts, although some exhibit chromosome
alignment defects that may be attributable to deformed nuclei in the
preceding interphase (Figure 3.2A, see Figure 2.12A). When we examined
extracts that had been co‐depleted of Vespera and the CPC, we observed
partial rescue of the CPC‐depletion phenotype. Microtubule polymerization
was largely restored, and though bipolar spindles did not form, many
groups of chromosomes formed half‐spindles (Figure 3.2A and 3.2B). We
speculate that the rescue of CPC depletion by Vespera co‐depletion may
require residual amounts of Aurora B in the extract that are insufficient to
fully restore spindle formation.
We also asked the converse question, and investigated whether co‐
depletion of CPC could rescue the Vespera defect in interphase. This was
indeed the case, as co‐depletion of Incenp restored normal, round shape in
∆Vespera extracts (Figures 3.2C and 3.2D). It appears that, directly or
indirectly, Vespera and Aurora B functionally oppose one another, and co‐
depletion of one can rescue the defects of individual depletion of the other.
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Figure 3.2. Vespera and Aurora B co‐depletion can suppress the
defects of individual depletions (A) CSF extracts containing
cycloheximide were depleted with control IgG‐beads, anti‐Incenp
beads, anti‐Vespera beads, or both anti‐Incenp and anti‐Vespera
beads. Sperm nuclei were added to these extracts and cycled through
interphase to metaphase. DNA was visualized with Hoechst 33258
(blue), and microtubules with rhodamine‐tubulin (red). Scale bar,
10μm. (B) Quantitation of structures observed in (A). Values shown
are the mean from two independent experiments, with ~200
chromosomal structures counted per sample per experiment. (C)
Sperm nuclei were assembled in extracts as in (A), and DNA was
stained with Hoechst 33258. Scale bar, 10 μm. (D) Quantitation of
structures observed in (C). Values shown are the mean from two
independent experiments, with ~200 nuclei counted per sample per
experiment.
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3.3

Vespera Reduces the Level of Aurora B‐Mediated Phosphorylation

To better understand the opposing relationship between Vespera and
Aurora B, we examined the phosphorylation status of Aurora B substrates
in the presence and absence of Vespera. Histone H3 serine 10 (H3S10) is a
well‐established Aurora B substrate, and its phosphorylation can be
detected by immunofluorescence using phospho‐specific antibodies (Hsu et
al., 2000).

Figure 3.3. Effect of excess Vespera on chromosomal H3S10
phosphorylation. Metaphase replicated chromosomes in the
presence or absence of excess (4.5 μM) Vespera recombinant
proteins were treated with nocodazole (to equalize the
chromosomal mass), and H3S10ph and Incenp were visualized by
immunofluorescence.

Average

and

standard

deviation

of

intensities of 40 chromosomal clusters per sample are shown.

First, we tested the effect of 10‐fold excess recombinant Vespera proteins in
H3S10 phosphorylation (H3S10ph). Consistent with the hypothesis that
Vespera

antagonizes

Aurora

B‐dependent

phosphorylation

(via

dephosphorylation), excess wild‐type Vespera, but not SUMOylation
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deficient K230R mutant protein, effectively reduced H3S10ph‐epitopes
(Figure 3.3). By contrast, the amount of Incenp was not affected by excess
Vespera.
Next, we monitored H3S10ph during the course of nuclear re‐
formation. Sperm nuclei were added to CSF extracts, and calcium was
added immediately to promote release from metaphase arrest to interphase.
As sperm nuclei contain histone H3, slight H3S10ph was transiently
observed at 15 min after addition of calcium (Figure 3.4). At this point, a
higher level of H3S10 phosphorylation was observed in ∆Vespera extracts
than in control extracts. Even though dephosphorylation is completed at 30
min in both extracts, chromosomes are not properly organized in ∆Vespera
extracts, suggesting that timely inactivation of the Aurora B pathway is
critical for proper nuclear re‐formation. Since the level of chromosome‐
associated Incenp was not affected by Vespera, Vespera does not appear to
act by controlling chromosomal recruitment of the CPC.
A similar result was observed when sperm nuclei were pre‐
incubated with CSF extracts for 45 min before the calcium addition (Figure
3.5A). In this experiment, H3S10 is well phosphorylated in both extracts
during the pre‐incubation in metaphase, but dephosphorylation of H3S10
and chromosome decondensation were delayed in ∆Vespera extracts upon
release to interphase. Similar results were obtained by monitoring
phosphorylation of another Aurora B substrate, Op18 (Figure 3.5B). These
results strongly suggest that Vespera is required for timely inactivation of
the Aurora B pathway at the exit from M phase.
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Figure 3.4. Effect of excess Vespera on chromosomal H3S10 phos‐
phorylation. Metaphase replicated chromosomes in the presence
or absence of excess (4.5 μM) Vespera recombinant proteins were
treated with nocodazole (to equalize the chromosomal mass), and
H3S10ph and Incenp were visualized by immuno‐fluorescence.
Average and standard deviation of intensities of 40 chromosomal
clusters per sample are shown. (D) Monitoring H3S10 dephos‐
phorylation on chromosomes upon interphase induction. Sperm
nuclei (200/μl) were added to control or ∆Vespera CSF extracts,
along with calcium. At the indicated timepoints, DNA was
stained with Hoechst 33258, and H3S10ph was visualized by
indirect immunofluorescence. Scale bar, 10 μm.

65

3.4 SUMOylated Vespera Promotes Recruitment of PP1 to Chromosomes
A recent study of global SUMO‐interacting proteins in budding yeast
showed that the protein phosphatase 1 (PP1), Glc7, binds to the yeast
homolog of SUMO, Smt3p (Makhnevych et al., 2009). It has been well
established that PP1 dephosphorylates Aurora B substrates and antagonizes
essential functions of Aurora B (Emanuele et al., 2008; Francisco et al., 1994;
Hsu et al., 2000). Because Glc7/PP1 is highly conserved between species, we
hypothesized that the interaction between PP1 and SUMO might be
conserved in Xenopus, and that SUMOylated Vespera might oppose Aurora
B function via PP1 recruitment to chromosomes.
To test this hypothesis, we purified metaphase chromosomes and
monitored the amount of associating PP1. While chromosomal levels of
Incenp, which is required for chromosome‐targeting and activation of
Aurora B, were unchanged, we saw that PP1 binding to chromosomes was
reduced in ∆Vespera extracts (Figure 3.6A). This reduced binding did not
reflect an overall reduction in PP1, as depletion of Vespera did not affect
cytoplasmic levels of PP1 (Figure 3.6B). Wild‐type Vespera, but not DNA‐
binding deficient mutant (K42R) or SUMOylation deficient mutant (K230R),
were able to rescue reduction of chromosome‐associated PP1 in ∆Vespera
extracts. As confirmed by anti‐Vespera antibodies, we observed that higher
levels

of

PP1

binding

to

chromosomes

SUMOylation (Figure 3.6A).
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correlated

with

Vespera

Figure 3.5. Aurora B Substrate dephosphorylation is impaired in
∆Vespera extracts. (A) Monitoring dephosphorylation of H3S10ph upon
interphase induction. Sperm nuclei (200/μl) were added to control or
∆Vespera CSF extracts and pre‐incubated for 45 min at 22°C. Calcium
was then added and, at the indicated timepoints, chromosomal
structures were fixed and spun down on coverslips. H3S10ph was
visualized by indirect immunofluorescence. Scale bar, 10μm. (B)
Monitoring Op18 dephosphorylation upon interphase induction. Sperm
nuclei (10000/μl) were added to control or ∆Vespera CSF extracts and
pre‐incubated for 45 min at 22°C before adding calcium and analyzing
by Western blot.
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Figure 3.6. Vespera depletion affects PP1 association with chromo‐
somes. (A) Western blot analysis of purified chromosomes.
Replicated metaphase chromosomes assembled in control or
∆Vespera extracts, in the presence or absence of recombinant
Vespera proteins were purified, and probed by Western blot with
the indicated antibodies. (B) Total protein from extracts in (A) was
analyzed by western blot using anti‐Vespera and anti‐PP1α
antibodies.

3.5

Discussion

In summary, we noted that the phenotypes we discovered for Vespera
(described in Chapter Two) are opposite from those that have been
previously attributed to Aurora B.

Based on this, we asked if co‐

depletion of Aurora B complex (CPC) could rescue depletion of Vespera.
We demonstrated that it could, that co‐depletion of Aurora rescued the
nuclear formation defect of Vespera depletion. The converse was also
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true, that co‐depletion of Vespera can rescue the spindle formation
defect CPC depletion. Aurora B is locally activated on chromosomes,
allowing it to promote spindle formation through inhibition of the
microtubule destabilizers MCAK and Op18 (Andrews et al., 2004; Gadea
and Ruderman, 2005; Lan et al., 2004; Ohi et al., 2003). Vespera is also
locally activated on chromosomes, as it appears to require chromatin‐
dependent SUMOylation for its activity.

Therefore, Aurora B and

Vespera represent two opposing functions that are both spatially
restricted to chromosome regions. We speculate that local activation of
Aurora B requires a corresponding localized de‐activation pathway to
efficiently execute the transition from metaphase‐to‐anaphase. At that
point, Aurora B is re‐localized from chromosomes to the spindle
midzone. Thus, in anaphase, Aurora B no longer phosphorylates
substrates

to

promote

microtubule

polymerization

around

chromosomes.
At the end of mitosis, Aurora B is removed from chromosomes,
and its substrates are dephosphorylated by cytoplasmic phosphatases.
We postulate that, in addition to this mechanism for inactivation of
Aurora B, Vespera represents an active pathway to reverse the effects of
Aurora B, allowing for rapid inactivation of its function on
chromosomes at anaphase. Our results show that, in the absence of
Vespera, Aurora B substrates are aberrantly retained on chromosomes
upon release from metaphase, indicating that Vespera is required for
timely inactivation of Aurora B on chromosomes. A very similar failure
to dephosphorylate Aurora B substrates in a timely fashion has been
reported in the absence of proper p97/Cdc48 activity, which causes
Aurora B itself to be improperly retained on chromosomes. Importantly,
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this scenario also resulted in failure to properly form interphase nuclei,
just as we observed for Vespera depletion.
We have demonstrated that, in order to oppose Aurora B
function, Vespera must be SUMOylated on chromatin. Vespera does not
appear to have any enzymatic function (or conserved enzyme domains),
and we hypothesize that it serves a signaling function via its
SUMOylation. We would like to know to what pathway Vespera signals
in order to functionally oppose Aurora B. One intriguing possibility is
the protein phosphatase PP1, which has been shown in various contexts
to dephosphorylate Aurora B substrates. PP1 was shown to interact
biochemically with the SUMO polypeptide in yeast, and since both PP1
and SUMO are well conserved, it is possible that this interaction is
present in higher eukaryotes. We demonstrated that full recruitment of
PP1 to chromosomes requires Vespera and its SUMOylation, providing
an attractive model for the functional opposition of Vespera and Aurora.
It remains to be established if this interaction is direct or indirect, and
further investigations will demonstrate if Vespera indeed opposes
Aurora B by recruitment of PP1 phosphatase.
Finally, in order to further understand the interplay between
kinase and phosphatases in signaling events in mitosis, we would like
tools for the detailed characterization of phosphorylation sites on
proteins.

In the following chapters, we will discuss a new mass

spectrometric method for the identification of phosphorylation, and our
application of this method to the CPC and Vespera.
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CHAPTER FOUR: A NEW METHOD FOR IDENTIFICATION OF
PHOSPHORYLATION USING MASS SPECTROMETRY

4.1

Introduction

Protein phosphorylation plays a central role in the regulation of many
cellular processes. In recent years, mass spectrometry (MS) has become a
method of choice for the analysis of protein phosphorylation (McLachlin
and Chait, 2001; Ptacek and Snyder, 2006; Reinders and Sickmann, 2005).
Although advances in instrumentation and software have made it possible
to perform large‐scale studies of phosphoproteomes (Li et al., 2007; Olsen et
al., 2006), the comprehensive analysis of phosphorylation in single proteins
remains challenging.
Detection of phosphorylation has been difficult due to the relative
suppression

of

phosphopeptide

MS

signals

compared

to

their

unphosphorylated counterparts. Thus, even when the unmodified peptide
can be observed as a strong peak in the spectrum, comparable amounts of
the unmodified peptide are often obscured by the background (Kang et al.,
1997; Zhou et al., 2000). Because of this difficulty, several approaches to
study phosphorylation involve removal of the phosphate group.

For

example, enzymatic treatment with phosphatase has been employed to
dephosphorylate proteins, resulting in an enhanced signal (Hirschberg et
al., 2004; Ishihama et al., 2007; Larsen et al., 2001; Liao et al., 1994;
Marcantonio et al., 2007; Torres et al., 2005; Zhang et al., 1998), but this
method has been shown to be subject to enzyme preferences (Hunter and
Games, 1994; Zeller and Konig, 2004). Alternatively, the phosphate group
has been converted to moieties that enhance detection, including affinity
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tags (Oda et al., 2001) or lysine analogs that are recognized and cleaved by
trypsin (Knight et al., 2003; Rusnak et al., 2004).
Tandem MS (MS‐MS) is frequently employed to confirm and map
phosphorylation sites, but here too the phosphate group is often removed.
Phosphate groups on amino acids are particularly unstable to collision‐
induced dissociation (CID), and are preferentially lost from the peptide as
the elements of phosphoric acid.

This loss of 98 Da provides a useful

phosphopeptide, and many studies have taken advantage of this property
to identify phosphorylation (Carr et al., 2005). For example, a neutral loss
scan can be performed to identify any species that displays this signature
loss, but this approach suffers from reduction in sensitivity arising from the
need to scan the entire m/z range of interest (Krutchinsky, 2007). This so‐
called “scanning disadvantage” can be partially overcome by targeting
either only discernable peaks in the spectrum (Casado‐Vela et al., 2007) or
by performing MS‐MS on a hypothetical subset of m/z values (Chang et al.,
2004). A major drawback of the former approach is its inability to analyze
species that are obscured by the background. Although the hypothesis‐
driven approach overcomes this difficulty, it is costly in terms of time and
sample.
In an effort to overcome some of the difficulties described above, we
have revisited the dephosphorylation approach, employing a chemical
dephosphorylation strategy. Hydrogen fluoride has been shown to rapidly
dephosphorylate phosphopeptides in solution (Kuyama et al., 2003), and we
have adapted this technique for use in‐gel and on whole proteins. This
chemical dephosphorylation results in enrichment of those unmodified
peptides

that

correspond

to

previously

phosphorylated

peptides.

Quantitative comparison of the signal‐to‐noise ratios of peaks in the treated
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versus untreated samples are used to identify phosphopeptides. The ability
to completely dephosphorylate proteins irrespective of amino acid sequence
and

the

improved

signal‐to‐noise

ratio

(S/N)

of

the

resulting

dephosphorylated peptides permit us to capture a mass spectrometric
phosphorylation “fingerprint” of a given protein. We have applied this
technique to characterize the phosphorylation of Aurora A, a centrosome‐
associated kinase whose auto‐phosphorylation has been previously studied
in detail (Haydon et al., 2003; Littlepage and Ruderman, 2002; Littlepage et
al., 2002).

4.2

In‐gel chemical dephosphorylation of peptides and proteins

As a test of our method for in‐gel chemical dephosphorylation, 1 μg
aliquots of three synthetic histone tail phosphopeptides (phosphorylated
respectively on serine, threonine, or tyrosine) were immobilized in a
polyacrylamide gel by electrophoresis and fixed with methanol‐acetic acid.
The precipitated peptides could be visualized directly in the gel, and were
cut out as 2mm slices.
70%

HF‐pyridine

dephosphorylation

for
of

The gel slices were dehydrated and treated with
one
the

hour

on

ice,

phosphoserine‐,

resulting

in

complete

phosphothreonine‐,

and

phosphotyrosine‐containing peptides, respectively (Figure 4.1). MS analysis
of the reaction products revealed that the phosphopeptides were
quantitatively converted to the unmodified backbone peptides with no
detectable side products.
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Fig. 4.1. In‐gel dephosphorylation of peptides. Polyacrylamide
gel slices containing peptides were dehydrated and incubated
with 70% HF‐pyridine for one hour on ice:

(A) ARKpSTGG‐

KAPRKQL, (B) ARKSpTGGKAPRKQL, (C) PSGGKATQASQE‐
pYC. Each spectrum shows before treatment (‐HF) and after
(+HF).
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Previously, this chemistry had been applied to peptides (Kuyama et
al., 2003). Here, we tested its ability to dephosphorylate whole proteins
using the model phosphoprotein ovalbumin. The protein was denatured by
boiling in SDS sample buffer, purified by SDS‐PAGE, and visualized by
Coomassie staining.

Gel slices were excised and destained, then

dehydrated and treated with HF as before. The gel slices were then washed
in 0.5M ammonium bicarbonate to bring the pH to ~8 prior to trypsin
digestion. Tryptic peptides were collected and analyzed by MALDI‐MS,
which demonstrated that the HF‐treated protein had been efficiently

Fig. 4.2. In‐gel dephosphorylation of protein. 5μg of ovalbumin were
purified by SDS‐PAGE, and gel slices containing the whole protein were
either not treated (‐HF) or treated (+HF) with 70% HF‐pyridine for one
hour on ice. The phosphopeptide EVVGpSAEAGVDAASVSEEFR (m/z =
2088.9) was dephosphorylated to yield the unmodified peptide (m/z =
2008.9).
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Figure 4.3.

Sensitivity of HF dephosphorylation for detecting

phosphorylation.

Varying amounts of β‐casein were either

untreated or treated with HF.

The peak corresponding to the

singly protonated phosphopeptide, RELEELNVPGEIVEpSLpSpSp‐
SEESITR (m/z = 3122.4) is shown for the untreated samples, and
the unmodified peak (m/z = 2802.4) is shown for the treated
samples.
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dephosphorylated (Figure 4.2). From these experiments, we conclude that
HF‐pyridine can efficiently dephosphorylate peptides, as well as whole
proteins, in gel. We observed that the signal‐to‐noise ratio (S/N) for the
dephosphorylated peak was significantly greater than the sum of the S/Ns
of the unmodified and phosphorylated peaks prior to HF treatment.
Dephosphorylated peptides should therefore be detectable down to lower
levels than the corresponding phosphorylated peptides.
To test this hypothesis, we analyzed varying amounts (400 fmol to 2
fmol) of the model phosphoprotein casein, comparing HF‐treated and
untreated samples. Casein is quadruply phosphorylated on its N‐terminal
tryptic peptide, and we observed, as before, that HF treatment efficiently
dephosphorylated the protein to yield the unmodified tryptic peptide
(Figure 4.3). The dephosphorylated peptide peak was readily discernable at
2 fmol, while the phosphopeptide peak did not rise significantly above the
background at 10 fmol. Thus, dephosphorylated peptide peaks are detected
with considerably enhanced S/N compared with their phosphorylated
counterparts.

4.3

Identification of Phosphorylation by Phosphopeptide Fingerprinting

We sought to take advantage of this enhancement of dephosphorylated
peptide signals upon HF treatment in order to efficiently identify
phosphopeptides. A schematic diagram of the method is depicted in Figure
4.4. As a test case, we examined tryptic peptides of ovalbumin, including
four phosphopeptides corresponding to two known phosphorylation sites.
We calculated the S/Ns for all ovalbumin peaks before and after HF
treatment, and found a striking division of the peaks into two populations
(Figure 4.5). The formerly phosphorylated peptides showed an increase in
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Figure 4.4.

Strategy for the identification of phosphorylation using

phospho‐peptide fingerprinting.
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Figure 4.5. The observed increase in S/N of unmodified peptides upon
HF treatment provides a “MS phosphopeptide fingerprint”, indicating
the likelihood that a given peptide is phosphorylated. The S/N was
calculated for peaks corresponding to unmodified peptides from
ovalbumin in HF‐treated and untreated samples. The log of the ratio of
S/Ns is plotted for each peptide to yield the “phosphopeptide index”.
Positive values were found to represent previously phosphorylated
peptides, while negative values represented unphosphorylated peptides.

signal‐to‐noise, while unmodified peptides showed a decrease, upon HF
treatment. Positive values for the phosphopeptide index were found to
correspond

to

phosphorylated

peptides,

and

negative

values

to

unphosphorylated peptides. Visual examination of the spectra confirmed
that peaks corresponding to dephosphorylated phosphopeptides showed an
increase in S/N upon HF treatment (Figure 4.6A), while unmodified peaks
showed a decrease in S/N (see, for example, Figure 4.6B).
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Figure 4.6. Signal‐to‐noise changes upon HF treatment. (A) Peaks
corresponding

to

dephosphorylated

versions

of

phosphopeptides increased in S/N upon HF treatment.
phospho‐peptides
protonated

are

EVVGpSAEAGVDAASVSEEFR

unmodified

m/z =

2008.9),

four

The four
(singly

DKLPGFGDpSIEAQ‐

CGTSVNVHSSLR (unmodified m/z = 2821.4), EVVGpSAEAGVDA‐
ASVSEEFRADHPFLFCIK (unmodified m/z = 3237.6), and ISQAV‐
HAAHAEINEAGREVVGpSAEAGVDAASVSEEF (unmodified m/z =
3763.8). (B) Unmodified peptide peaks showed a decrease in S/N
with HF.

The example shown here is NVLQPSSVDSQTAM‐

VLVNAIVFK (m/z = 2460.3).
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4.4

Identification of In vitro Autophosphorylation Sites on Aurora A

Kinase
We tested our approach on the recombinant Xenopus laevis phosphoprotein,
Aurora A kinase.

Subsequent to in vitro autophosphorylation in the

presence of ATP, SDS‐PAGE analysis showed an additional mobility shift
for Aurora A (Figure 4.7A). The shifted band was excised from the gel and
split into four samples, which were digested with trypsin or Glu‐C and
either treated or not treated with HF.

These four samples were then

analyzed by single‐stage mass spectrometry, and a phosphopeptide index
was calculated for each unmodified Aurora A peak (Figure 4.7B).

The

phosphopeptide indexes generally correlated well with phosphorylation, as
gauged by the S/N of the peak for neutral loss of phosphoric acid (98 Da) in
MS‐MS. Thus, of the ten peptides with a positive phosphopeptide index,
nine were verified as phosphorylated by clear detection of the 98 Da
signature loss (i.e., with a S/N>2). The phosphorylation modifications on
these nine phosphopeptides were mapped by tandem MS, yielding eight
phosphorylation sites that all agreed with previous characterizations of
Aurora A phosphorylation (Haydon et al., 2003; Littlepage and Ruderman,
2002; Littlepage et al., 2002).

None of the peptides with a negative

phosphopeptide index was found to be phosphorylated.
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Figure 4.7. Determination of Aurora‐A autophosphorylation sites. (A)
Recombinant Xenopus Aurora‐A displays reduced mobility in SDS‐
PAGE upon incubation with ATP. (B) Autophosphorylation sites of
Aurora‐A were found by MS phosphopeptide fingerprinting and
confirmed by MS‐MS and MS‐MS‐MS. The S/Ns for all unmodified
Aurora‐A peptides are shown in the table, along with the S/Ns for the
peaks corresponding to the loss of phosphoric acid in the MS‐MS of the
corresponding phosphopeptides. The residues that were found to be
phosphorylated are indicated in red.
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4.5

Comparison to Other Methods

We compared our MS phosphopeptide fingerprinting approach to two
other established methods using phosphorylated Aurora A as a test case,
and found that it was the most efficient for finding phosphopeptides
(Figure 4.8). Our method found all 9 phosphopeptides in the first 10
peptides tested. By comparison, analysis of all hypothesized Aurora A
phosphopeptides in mass order (i.e., the hypothesis‐driven multiple‐stage
MS approach (Chang et al., 2004) yielded all nine phosphopeptides in the

Figure 4.8. Comparison of MS phosphopeptide fingerprinting to other
methods. MS phosphopeptide fingerprinting (method 1, red) identifies
phosphopeptides more efficiently than hypothesis‐driven multistage MS
(method 2, blue) and fragmentation of the 300 most intense peaks in the
spectrum (method 3, black).
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sample, but only after examining 84 peptides. A neutral loss scan approach
that analyzed the top 300 most intense peaks in the spectrum found only 4
of the 9 phosphopeptides, indicating that many phosphopeptides are not
well‐detected directly by MS.
4.6

Discussion

In summary, we show that chemical dephosphorylation is an effective
method for generating an “MS phosphopeptide fingerprint” that permits
rapid identification of phosphopeptides by MS. This approach uses MS data
to determine candidate phosphopeptides that can be confirmed with
efficient consumption of sample by tandem MS analysis. It takes advantage
of the S/N enhancement that is generally observed upon dephosphorylation
of phosphopeptides; smaller phosphopeptide signals are converted to larger
unphosphorylated peptide signals.

We have applied our technique to the

analysis of model phosphoproteins, as well as in vitro phosphorylated
proteins. In the next chapter we will discuss application of this method to
in vivo samples.
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CHAPTER FIVE: IDENTIFICATION OF PHOSPHORYLATION
SITES ON VESPERA AND THE AURORA B CHROMOSOME
PASSENGER COMPLEX

5.1

Introduction

Having validated our method on model phosphoproteins and a known in
vitro phosphorylation reaction, we wished to apply it to in vivo samples. A
rapid and efficient method for the identification of phosphorylation is
particularly useful in studying mitosis, where phosphorylation signaling
appears to be of central importance. The order and timing of events in the
cell cycle are coordinated by cyclin‐dependent kinases (Cdks), which
phosphorylate different substrates, depending on their association with
different cyclin binding partners. These phosphorylation events trigger
biochemical switches that initiate signaling cascades and thereby direct the
progression of the cell through various phases of the cell cycle (Morgan,
1997).

Comprehensive knowledge of the phosphorylation sites that are

associated with different activities in the cell cycle will be crucial to
understanding the cell‐cycle control system.
Here, we apply our method to identify in vivo phosphorylation sites
on four members of the CPC‐‐Aurora B, Incenp, Dasra A, and Survivin—
that were immunoprecipitated from Xenopus egg extracts using anti‐Incenp
antibodies. In addition, we observe a cell cycle‐dependent mobility shift on
Vespera, and we identify phosphorylation sites on immunoprecipitated
Vespera that account for this shift.

For both Incenp and Vespera, we

identify Cdk consensus phosphorylation sites which suggest mitotic
regulation of these proteins. We also show that Vespera phosphorylation is
not required for its SUMOylation.
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5.2

Identification of Phosphorylation Sites on the Aurora B

Chromosome Passenger Complex (CPC)
We applied the MS phosphopeptide fingerprinting approach to the
Chromosome Passenger Complex (CPC), purified from Xenopus egg
extracts. Aurora B has been previously shown to phosphorylate itself as
well as the other CPC complex members by incorporation of 32P, but not all
of the in vivo phosphorylation sites have been mapped (Bishop and
Schumacher, 2002; Honda et al., 2003; Sessa et al., 2005; Wheatley et al.,
2004; Yasui et al., 2004). Phosphorylation serves to activate the CPC, which
is normally suppressed in the cytoplasm, but active on chromatin. This
phosphorylation and activation can be induced either by the addition of
phosphatase inhibitors or by clustering of the complex on chromatin (Kelly
et al., 2007). We therefore examined the phosphorylation of CPC members
in Xenopus egg extracts that had been treated with a phosphatase inhibitor
(okadaic acid) or a control (DMSO).
Certain of the immunoprecipitated CPC components from extracts
that were treated with okadaic acid showed shifts in SDS‐PAGE, compared
to DMSO control, consistent with phosphorylation (Figure 5.1A).

The

regions containing the phosphorylated CPC proteins were excised from the
gel and the phosphorylated peptides were identified using our MS
phosphopeptide fingerprinting method (Figure 5.1B).

CPC peptides that

yielded a positive phosphopeptide index were subjected to MS‐MS and MS‐
MS‐MS analysis, confirming that these peptides were phosphorylated. In
several cases, we were also able to identify the precise sites of
phosphorylation. Aurora B is known to bind and phosphorylate the C‐
terminal region of Incenp, resulting in a positive feedback loop that further
stimulates Aurora B activity via autophosphorylation of its activation loop
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(Bishop and Schumacher, 2002; Yasui et al., 2004). Our analysis indicates
that these phosphorylation events occur in Xenopus egg extracts, after

Figure 5.1. Chromosome Passenger Complex (CPC) Phos‐
phorylation. (A) CPC was immunoprecipitated from Xenopus egg
extracts treated with DMSO control or okadaic acid (phosphatase
inhibitor), and analyzed by SDS‐PAGE. (B) Phosphopeptides
were identified for Incenp, Aurora B, and Dasra A.
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treatment with okadaic acid, but not DMSO. Incenp was found to be triply‐
phosphorylated on a peptide containing Thr‐848, Ser‐849, and Ser‐850, and
Aurora B was phosphorylated at Thr‐248.
In addition to these known sites, we found phosphorylation on
Incenp at Ser‐277, and on Aurora B at Thr‐56. Interestingly, Thr‐56 is a
cyclin‐dependent kinase (Cdk) consensus site, which may indicate Cdk
regulation of Aurora B, as has been previously suggested for Incenp (Goto
et al., 2006). We also found a peptide in the N‐terminal region of Dasra A
that was quadruply phosphorylated on Ser‐63, Ser‐65, Thr‐66, and Thr‐67,
though the functional significance of this non‐conserved region has yet to be
determined. In addition, two other phosphopeptides (one each for Aurora
B and Dasra A) were found and confirmed by MS‐MS‐MS, but the precise
phosphorylation sites within these peptides could not be localized.

5.3

Identification of Vespera Phosphorylation

In addition to its SUMOylation upon binding DNA, we observed that
Vespera exhibits a DNA‐independent mobility shift in mitosis (Figure 5.2A).
We speculated that this shift was due to phosphorylation, and mapped
three

phosphorylation

sites

on

endogenous

Vespera

using

MS

phosphopeptide fingerprinting (Figure 5.2B) (Woo et al., 2008). These sites
included Ser‐183, Ser‐226, and Ser‐234. We noted that Ser‐183 matches an
Aurora kinase consensus site, [RX(S/T)], while Ser‐226 and Ser‐234 are both
Cdk consensus sites, [(S/T) P] (see Figure 5.4). We therefore mutated these
residues to alanine or acidic residues, and tested the mutants to see if they
still displayed a cell cycle‐dependent mobility shift. We treated the pair of
Cdk consensus sites, Ser‐226 and Ser‐234, as one unit, mutating them in
tandem. When we did the analysis, we observed that Aurora‐site (S183)
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mutants still shifted in metaphase, like wild‐type, but that Cdk‐site (S226,
S234) mutants no longer did so (Figure 5.3).

Figure 5.2. Phosphopeptide Mapping of Vespera. (A) Cell‐cycle‐
dependent mobility shift of Vespera. In the absence of DNA, total
protein

from

interphase

extract,

metaphase

extract,

and

metaphase extract treated with the Cdk inhibitor purvalanol were
analyzed by Western blotting using anti‐Vespera antibodies. (B)
Phosphopeptide finger‐printing analysis of immunoprecipitated
Vespera from metaphase extract identified two phosphopeptides.
We therefore concluded that phosphorylation of Cdk‐consensus S226
and/or S234 is required for the observed mitotic shift of Vespera. This is
most likely due directly to Cdk‐dependent phosphorylation of these sites.
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Figure 5.3. Mutational analysis of Vespera phosphorylation sites.
35

S‐labeled, in vitro‐translated wild‐type or mutant Vespera as

indicated was incubated for 45 min at 22°C with CSF extract
containing cycloheximide, with (M) or without (I) calcium to
induce interphase. For each sample, 0.5μl of extract was analyzed
by SDS‐PAGE and autoradiography.

In summary, we have identified several modifications on Vespera
that cluster in its C‐terminus (Figure 5.4).

These include a single site

required for poly‐SUMOylation on chromatin, an Aurora kinase consensus
site, and two Cdk consensus sites that are needed for modification of
Vespera in metaphase.
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Figure 5.4. Vespera sequence and modifications.

5.4

Vespera Phosphorylation Is Not Required for its SUMOylation

SUMOylation of Vespera requires DNA‐binding, but we observe the mitotic
shift in Vespera in the absence of DNA. Therefore, we infer that Vespera
SUMOylation is not required for its phosphorylation. We next asked if
SUMOylation of Vespera is dependent on phosphorylation by mutating the
phosphorylation sites we had identified and visualizing the chromatin‐
bound constructs. All of the phosphorylation mutants we tested were
SUMOylated on chromatin, so mitotic phosphorylation does not appear to
be required for SUMOylation (Figure 5.5).

This is consistent with our

observation that Vespera SUMOylation is not cell cycle‐dependent (see
Figure 2.7).
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Figure 5.5.

Vespera phosphorylation is not required for its

SUMOylation. 35S‐labeled, in vitro‐translated wild‐type or mutant
Vespera proteins were added to metaphase extracts containing
cycloheximide and incubated for 40 min at 22°C. DNA‐beads
were added to the extracts and incubated for an additional 40
min, then isolated and purified.

The DNA‐beads‐associated

proteins were visualized by SDS‐PAGE and autoradiography.
Arrow

indicates

unmodified

Vespera,

mono‐SUMOylated

Vespera, and bracket indicates poly‐SUMOylated Vespera. The
doublet is an artefact of in vitro translation.

5.5

Discussion

From our analysis of the CPC and Vespera purified from Xenopus egg
extracts, we conclude that MS phosphopeptide fingerprinting can
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successfully identify phosphopeptides isolated in vivo.

Although our

method is highly effective for finding phosphopeptides, the confirmation
and unambiguous localization of the precise phosphorylation sites can still
be very difficult, as observed with members of the CPC. While the neutral
loss of phosphoric acid in CID provides useful confirmation of a
phosphopeptide, the loss of the phosphate group often makes it difficult to
pinpoint its location.

In the future, we plan to combine the current

approach with fragmentation techniques such as electron transfer
dissociation (ETD) or electron capture dissociation (ECD), which promote
peptide bond breakage without loss of phosphate groups.

We have

demonstrated this technique using MALDI, but we believe it should be an
effective method for electrospray ionization as well.
A phosphopeptide index can be calculated for any peptide without
prior knowledge of the sample. Thus, even when the protein sample is
unknown, MS phosphopeptide fingerprinting should be an effective
method for the identification of phosphopeptides. The HF‐treated samples
can also provide additional peptides for protein identification, especially in
cases where the identification of a phosphoprotein might be complicated by
heavy modification.
Our analysis of CPC and Vespera has identified previously unknown
phosphorylation sites. We demonstrated that Vespera phosphorylation is
not required for its SUMOylation, and therefore, we would predict, for the
SUMOylation‐dependent functions we observe. Nevertheless, the sites we
identified match known consensus sites for Aurora and Cdk, two kinase
families that are important in mitosis, and this suggests that there are cell
cycle‐regulated roles for these modifications. Future studies are required to
elucidate these roles, as well as those for the new phosphorylation sites
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identified

in

Incenp,

Aurora

B,

and

Dasra

A.

Cdk‐dependent

phosphorylation of Aurora B at Thr‐56 may be of particular interest, since
direct regulation of Aurora B by Cdk has not yet been described. Finally,
though

we

observed

Survivin

association

with

CPC

in

our

immunoprecipitated complexes, we did not observe phosphorylation of
Survivin under the conditions of our experiment. Survivin phosphorylation
by Aurora B has been reported in vitro (Wheatley et al., 2004), and
dominant‐negative

phosphorylation‐site

mutants

produced

spindle

abnormalities in Xenopus egg extracts (Canovas and Guadagno, 2007). More
studies of endogenous Survivin are needed to identify the in vivo context for
Survivin phosphorylation, and its biological functions.
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CHAPTER SIX:
GENERAL DISCUSSION

6.1

Vespera Conservation and Function in Early Development

We have identified Vespera as a protein that is important for nuclear
reassembly in Xenopus egg extracts. Nuclear re‐formation in telophase is a
fundamental process in all eukaryotic cells with an open mitosis, but
Vespera is evolutionarily not well conserved.

The closest mammalian

homologs of Vespera are Dppa2 (Developmental pluripotency associated)
and Dppa4, with 21.6% overall identity between the frog and human
proteins, much of which is accounted for by their SAP domains (Figure
6.1A). Interestingly, the C terminus of Vespera is also fairly well conserved
(Figure 6.1B), as has been reported for the mammalian proteins
(Maldonado‐Saldivia et al., 2007). This higher level of conservation
coincides with the clustering of the modifications we mapped (see Figure
5.4) and may reflect conserved modification patterns.
Dppa2 and Dppa4 expression is restricted to embryonic pluripotent
cells, and similarly, we find that expression of Vespera mRNA is restricted
to eggs and early embryos (Figure 6.2). The modest sequence conservation
and embryonic expression of Vespera raise questions about the generality of
its function. Because Xenopus eggs and early embryos are substantially
larger than their nuclei and spindles, these cells may have a unique
requirement for active disassembly of microtubules from chromosomes.
Xenopus egg extracts can assemble spindles around DNA‐beads in the
absence of centrosomes, and it has been suggested that the eggs and early
embryos have an enhanced ability to promote microtubule polymerization
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from chromosomes.

We speculate that Vespera may represent a

corresponding enhanced ability to destabilize microtubules around
chromosomes, to promote proper spindle disassembly in these systems.

Figure 6.1. Conservation of Vespera. (A) Sequence alignment of
the SAP domains of Xenopus Vespera and mammalian
homologs Dppa2 and Dppa4. Conserved lysine that contacts
DNA is marked with an asterisk (*) (B) Sequence alignment of
the C termini of Xenopus Vespera and mammalian homologs
Dppa2 and Dppa4. The identified sites for covalent attachment
of phosphate and SUMO modifications are marked with
asterisks (*).

96

Figure 6.2.

Embryonic Expression of Vespera mRNA. Embryos

from the indicated stages were collected and RNA was extracted
and subjected to RT‐PCR analysis using primers for Vespera and
ornithine decarboxylase, a loading control for mRNA recovery.

6.2

Special roles for microtubules in oocytes and eggs

To facilitate early embryonic divisions, many eggs are large and contain
stores of mRNA and proteins needed for initial cell cycles upon fertilization.
Furthermore, many meiotic spindles lack centrosomes, and it has been
shown that spindle assembly can occur in Xenopus egg extracts around
DNA‐coated beads in the absence of centrosomes (Heald et al., 1996).
Therefore, the self‐organization of microtubules around chromosomes to
form a spindle in oocytes and early embryos often presents a unique
challenge for these cells. Studies of acentrosomal spindles in mouse oocytes
described

a

Ran‐dependent

dramatic
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increase

in

microtubule

polymerization following nuclear envelope breakdown in maturing
oocytes. These spindles appeared to go through a large ʺMicrotubule Ballʺ
stage before activities of motors like kinesin‐5 organized the microtubules
into bipolar spindle structures (Schuh and Ellenberg, 2007). It appears that
in some systems, at least, microtubule polymerization is particularly active
at these stages, in order to nucleate mitotic spindle structures in a relatively
large volume of cytoplasm. It follows, then, that specialized microtubule‐
destabilizing activities might be required to counteract embryonic
microtubule polymerization around chromatin, at the appropriate times,
and Vespera may represent one such pathway. Interestingly, in starfish
oocytes, it was shown that asters are too short to capture chromosomes in
these large cells, but that in this case a contracting actin network helps to
drive spindle assembly (Lenart et al., 2005).

Actin is not required for

spindle assembly in mouse oocytes, but apparently these cells have
capitalized on enhanced microtubule polymerization to solve the challenge
of spindle assembly in large cells (Wassarman and Fujiwara, 1978).
Similarly, large amounts of microtubule polymerization appear to facilitate
migration and fusion of sperm and egg pronuclei in mouse fertilization
(Schatten et al., 1985).

6.3

Chromosome‐Induced SUMOylation in mitosis

As we have discussed, Vespera is embryonically expressed and poorly
conserved.

This may reflect a specialized role for this protein in early

embryos, but another possibility is that Vespera acts chiefly through its
SUMOylation, allowing the Vespera sequence substantial evolutionary
flexibility.
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Like Aurora B‐dependent phosphorylation, SUMOylation has been
shown to be stimulated on metaphase chromosomes in Xenopus egg extracts
(Azuma et al., 2003).

Of the chromatin‐induced SUMOylation substrates,

Topoisomerase II is a major target, but we have now identified Vespera as
another one. Like Topo II, SUMOylation of Vespera is dependent on the
SUMO E3 ligase PIASy in the Xenopus egg extract system. We identified
K230 on Vespera as solely required for its SUMOylation, leading us to
conclude that this is the attachment site for SUMO chains (though we
cannot formally rule out its requirement in SUMOylation of Vespera by
another mechanism).
Our findings that SUMO‐Vespera has a negative effect on
microtubules suggests a chromatin‐based mechanism for the local
depolymerization of

microtubules.

This can serve to balance the

chromatin‐induced microtubule polymerization activities attributed to the
Aurora B (CPC) and Ran pathways. In contrast to observations for Aurora
B, we find that Vespera is bound to chromatin and SUMOylated throughout
the cell cycle, so perhaps Vespera is constantly active on chromatin, with its
activity dominating spindle dynamics only when Aurora B is removed from
chromatin in anaphase. We provide preliminary evidence that Vespera is
involved in recruitment of protein phosphatase PP1 to chromatin, via
SUMOylation of Vespera. We note that as a general principle in covalent
modification‐based signaling, the use of one type of modification to recruit
an enzyme that affects a different type of modification (in this case, SUMO
recruitment of phosphatase), can be useful, in that the two modules do not
interact with one another, resulting in undesirable signal interference.
Although we showed that PIASy‐dependent Vespera SUMOylation
promotes nuclear formation in Xenopus egg extracts, PIASy depletion does
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not have an apparent effect on this process (data not shown and (Azuma et
al., 2005)). This apparent conflict can be reconciled by our observation that
spindle size was reduced in PIASy‐depleted extracts (see Figure 2.17),
suggesting that PIASy contributes to microtubule stabilization (thereby
opposing Vespera), by independent means.
SUMO modifications have been implicated in diverse cellular
processes, and the mechanisms are increasingly found to involve
recognition of SUMO by proteins containing SUMO‐interacting motifs
(SIMs). These motifs are characterized by a hydrophobic core flanked by
acidic residues (Hecker et al., 2006). Recent large‐scale studies have
identified yeast PP1 as a SUMO‐interacting protein that contains these
motifs (Makhnevych et al., 2009), which are conserved in vertebrates.
Further studies are required in order to characterize the interaction between
SUMOylated Vespera and PP1 or other SIM‐containing proteins.

6.4

Microtubules and the Nuclear Envelope

Our results indicate a connection between disassembly of spindle
microtubules and nuclear re‐formation at the end of mitosis. In organisms
with an open mitosis, the dynamics of the nuclear envelope and spindle
microtubules represent some of the most dramatic structural features of the
cell division process. From the earliest high‐resolution imaging studies of
this process, a relationship has been noted between microtubules and the
nuclear envelope.
Electron microscopy studies of nuclear envelope breakdown (NEBD)
in prophase revealed that the process was characterized by formation of
invaginations in the lamina that were occupied by microtubules (Georgatos
et al., 1997).

This led to the hypothesis that microtubules participate in
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active tearing of membrane fragments to promote NEBD. When cells were
treated with nocodazole, however, NEBD still occurred, though the process
appeared qualitatively different.

More recently, higher‐resolution live

imaging of microtubules and nuclear envelope components also reported
the formation of prophase invaginations, and showed that the first tearing
site consistently forms in regions away from chromosomes (Beaudouin et
al., 2002).

Microtubules were observed to form asters within these

invaginations, and these asters were shown to recruit dynein (Salina et al.,
2002).

Overexpression of dominant‐negative dynactin disrupted this

dynein localization and delayed NEBD. In contrast to the prior report,
nocodazole treatment delayed NEBD in this study. The differences could
be explained by varying experimental handling, but normal rat kidney
(NRK) cells were used in both cases. Therefore, microtubules appear to
play an ill‐defined nonessential role in the process of NEBD, perhaps to
ensure the timely execution of the process.
If microtubules promote NEBD in prophase, is it possible they
provide an obstacle to nuclear re‐formation in telophase? In the transition
from mitosis to interphase, chromosomes must switch from promoting local
microtubule polymerization to attracting components of the nuclear
envelope. To some extent this is achieved by signaling pathways. At the
end of mitosis, the Triple A‐ATPase p97/Cdc48 extracts Aurora B from
chromatin and preceding its re‐localization to the central spindle, a process
that has been shown to be required for proper nuclear re‐formation
(Ramadan et al., 2007). In yeast, this re‐localization is mediated by Cdc14
dephosphorylation of the Aurora‐interacting protein Sli15 (homolog of
Incenp), and is required for proper spindle disassembly. Therefore, re‐
localization of the Aurora B Chromosome Passenger Complex (CPC) has
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been shown to be required for both spindle disassembly and nuclear re‐
formation at the end of mitosis. It is possible that Aurora B has central
spindle‐specific substrates that are required for these events, but the CPC
has also been characterized to promote microtubule polymerization from
chromosomes (Kelly et al., 2007; Sampath et al., 2004). Therefore a simpler
model, given the results to date, is that the CPC must be re‐localized in
order

to

suppress

its

microtubule

polymerizing

activities

from

chromosomes at anaphase, when such activities are no longer desirable.
Further clues that spindle microtubules provide a direct challenge for
the newly‐forming nuclear envelope come from immunofluorescence
studies of telophase.

Imaging analysis of fluorescently‐tagged lamin B

receptor, which is recruited to chromatin in the nuclear re‐formation
process, reported that the protein appears to favor regions of lower
microtubule density (Chaudhary and Courvalin, 1993). A higher‐resolution
version of this study confirmed that nucleation of lamin B receptor begins
on the side of the chromatin mass opposite sites of microtubule attachment
(Gerlich et al., 2001).

Recently,

careful timecourse analyses of several

nuclear envelope proteins in telophase has revealed that there appear to be
two different modes of recruitment of lamina proteins to chromatin (Dechat
et al., 2004; Haraguchi et al., 2008). In the first mode, exemplified by lamin
B receptor, nuclear envelope components are recruited to regions away
from spindle microtubules. In the second mode, displayed by proteins such
as LAP2α, emerin, and BAF, recruitment appears localized specifically to
the region of chromatin surrounding microtubule attachment (termed the
ʺcoreʺ region in these studies). Importantly, these two modes of recruitment
appear to reflect differing modes of nuclear re‐formation, as the nuclear
envelope consistently encloses the surrounding chromatin before the ʺcoreʺ
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region (Figure 6.3C). The delay in forming nuclear envelope at the site of
spindle attachment further suggests that microtubules present a special

Figure 6.3. Depletion of a chromatin‐NE adaptor protein, BAF, results in
increased microtubules in the telophase chromatin body, adapted from
(Haraguchi et al., 2008). Live‐correlated EM analyses of HeLa cells
expressing GFP‐BAF after siRNA treatment (B) or luciferase siRNA
treatment as a control (A). During time‐lapse imaging of living HeLa
cells expressing GFP‐BAF, cells were fixed 7 minutes after the
metaphase‐anaphase transition and subjected to EM analysis. Drawings
are superimposed on the EM images indicating GFP‐BAF (green), the
NE (red), and MTs (orange). Scale bar, 500 nm. (C) Model of NE
formation in the control siRNA‐treated (left) and BAF siRNA‐treated cell
(right).
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challenge to that process, and it appears that a specialized ʺcoreʺ complex of
proteins is recruited to the region to meet this challenge.
The DNA‐binding protein BAF has been shown to be required for
recruitment of LEM domain‐containing nuclear envelope proteins such as
emerin to this chromatin ʺcoreʺ region, and therefore appears to be a key
player in forming this structure (Haraguchi et al., 2001).

By

immunofluorescence, BAF was observed to bind to microtubules prior to its
concentration at the ʺcoreʺ region. When cells are treated with nocodazole
to depolymerize microtubules, BAF is no longer recruited to telophase
chromatin. Based on these observations, the authors of this study postulate
that microtubules are required for ʺcoreʺ formation and promote assembly
of these proteins on chromatin. This is no doubt demonstrated by their
results, but another interpretation is that in the absence of microtubules,
ʺcoreʺ complex recruitment is simply not needed, because the ʺcoreʺ
complex exists for the special purpose of disrupting chromatin‐microtubule
attachments. In this model, BAF binds to microtubule for the purpose of
navigating to sites of chromatin‐microtubule attachment, in order to
promote nuclear envelope formation in those regions.

More detailed

studies of nuclear envelope assembly in the presence of nocodazole are
needed to distinguish between different models. For example, it would be
useful to know the localization of lamin B receptor in the presence of
nocodazole (perhaps it coats the entire chromatin body), as well as the effect
of nocodazole treatment on the process of nuclear re‐formation as a whole.
Our studies in Xenopus egg extracts suggest that the formation of functional
interphase nuclei is not affected by nocodazole treatment (see Figure 2.19).
Haraguchi et al. have also provided valuable insight into the
relationship between microtubules and nuclear envelope formation through
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the use of time‐resolved electron microscopy (Haraguchi et al., 2008). Four
minutes after the metaphase‐to‐anaphase transition, the core region is not
very prominent, nuclear membrane has not yet formed, and microtubules
can be observed to penetrate into the chromatin mass. About three minutes
later, the core complex can be observed, and nuclear membrane has started
to form outside of the core. At this time, microtubules were found in gaps
in the core, or seen to extend to the region of core complex and stop, as if
the core complex might be inhibiting their further polymerization. Finally,
ten minutes following the metaphase‐to‐anaphase transition, the nuclear
membrane is largely formed, with a small remaining region of core
accumulation. Again, in this case, it appears that core regions are refractory
to microtubules. These studies also revealed dramatic changes upon siRNA
depletion of BAF, which appears crucial for core complex formation. In the
absence of BAF, the core complex was not observed to form, and relatively
long microtubules persisted in the chromatin mass late into anaphase
(Figure 6.3A and 6.3B).

These observations demonstrate that BAF is

required for core complex formation.

They suggest that this complex,

which is localized on chromatin to regions of spindle‐microtubule
attachment, plays a role in disassembling microtubules around chromatin in
anaphase. Furthermore, the relatively rapid formation of nuclear envelope
around regions of chromatin that are devoid of microtubules suggest that
chromatin‐microtubule attachments impede the recruitment of nuclear
envelope components. These results, like those of our study, suggest that
microtubules must be depolymerized around chromatin to promote proper
nuclear re‐formation at the end of mitosis.
6.5

A Model for the Coordination of Spindle Disassembly and Nuclear

Re‐formation
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Our review of detailed imaging studies summarizes the circumstantial
evidence that microtubules are involved in nuclear envelope formation. It
remains unclear from the images whether microtubules contributed
positively or negatively to the process, but our analysis of Vespera in
Xenopus egg extracts suggests that microtubules interfere with nuclear re‐
formation.

In

metaphase,

chromosomes

nucleate

microtubule

polymerization to promote spindle formation, but in interphase, chromatin
attracts nuclear envelope components to promote nuclear formation. A
fundamental question, then, is how does chromatin distinguish between
these radically different structures at different points in the cell cycle? Our
model for the regulation of these chromatin‐induced functions is depicted
in Figure 6.4, which shows the opposing roles for Aurora B and Vespera in
these processes. From prophase to metaphase, Aurora B kinase is localized
to chromosomes (see Figure 1.10) where it promotes microtubule
polymerization and spindle assembly, and inhibits nuclear formation.
Meanwhile, Vespera is SUMOylated on chromatin where it acts to
negatively regulate microtubules and promote nuclear formation. While
Aurora B is active on chromosomes, it activity dominates, but when Aurora
B is re‐localized from chromosomes to the spindle midzone at the start of
anaphase, Vespera activity dominates. SUMOylated Vespera potentially
acts directly on the Aurora B pathway by recruiting PP1 phosphatase to
locally dephosphorylate Aurora B substrates around anaphase chromatin.
This facilitates microtubule depolymerization around chromatin, thereby
permitting proper nuclear formation as the cell proceeds to interphase.
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Figure 6.4. A model for opposing action of Vespera and Aurora B on
spindle assembly and nuclear formation around chromatin. Aurora B
is

known

to

promote

chromosome‐associate

microtubule

polymerization, which is required for spindle formation. We have
introduced a new protein, Vespera, which is SUMOylated on
chromatin and destabilizes microtubules. Taken together, our results
suggest that microtubules are inhibitory to nuclear formation. This
explains the requirement of Vespera in proper nuclear assembly, and
the prior observation that Aurora B inhibits this process.
phosphatases

directly

dephosphorylation of

opposes

Aurora

B

function

PP1
by

its targets, and we provide preliminary

evidence that SUMO‐Vespera is involved in PP1 recruitment to
chromatin.
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6.6

Concluding remarks

Our results show that, upon completion of mitosis, the disassembly of
spindle components and reassembly of nuclear structures must be locally
coordinated around chromatin. Previous studies have suggested that an
important step in this process is the inactivation of the Aurora B kinase by
the Triple A‐ATPase Cdc48/p97, which physically extracts the protein from
chromatin at anaphase. Aurora B is the catalytic subunit of the CPC, which
promotes microtubule polymerization and spindle formation from mitotic
chromosomes. We postulate that removal of the CPC from chromosomes at
anaphase is required for proper spindle disassembly and nuclear
reassembly, and that additionally, an opposing activity is localized to
chromatin to promote rapid inactivation of Aurora B activity upon its
removal.
Using Xenopus egg extracts and mass spectrometry, we discovered
Vespera, a protein which is functionally antagonistic to the CPC.

We

showed that Vespera promotes microtubule depolymerization from
chromosomes and is required on chromatin for proper nuclear formation.
We initially identified Vespera as a protein that is specifically SUMOylated
upon interaction with chromatin, a modification that is dependent on the
SUMO E3 ligase, PIASy. Immunodepletion of Vespera from Xenopus egg
extracts interfered with proper nuclear formation and nuclear transport,
and rescue of this defect required Vespera SUMOylation.

Addition of

excess amounts of Vespera to metaphase extracts disassembled spindle
microtubules, and this activity was also dependent on SUMOylation of
Vespera and PIASy. Importantly, the Vespera depletion defect in nuclear
formation could be rescued by nocodazole or by co‐depletion of the CPC.
These manipulations depolymerize microtubules, suggesting that the
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microtubule‐depolymerizing activity of SUMO‐Vespera is central to its role
in ensuring proper nuclear formation.

Our results suggest that

microtubules must be actively depolymerized around chromosomes to
permit proper nuclear reassembly, a process that is promoted by
SUMOylated Vespera.
In conclusion, we have discovered a novel chromatin‐localized
microtubule disassembly activity, which appears to play an important role
in nuclear re‐formation at the end of mitosis.

The mechanism of this

function remains unclear, and further studies will be required to uncover
the molecular mechanisms of Vespera activity.

MS‐based proteomic

approaches using SUMOylated Vespera will be valuable in determining if
the hypothesized connection between SUMO‐Vespera and PP1 is direct.
We have also reported a new MS method for the efficient identification of
phosphorylation, and application of this method to identification of
phosphorylation signaling pathways such as those directed by Aurora B
kinase and opposing PP1 phosphatase will be of great use in achieving a
more detailed understanding of cell cycle processes.
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APPENDIX I:
LIST OF PROTEINS IDENTIFIED BY MASS SPECTROMETRY
I.1 Chromatin‐binding proteins found in Interphase
Accession numbers

kD

Gene description

gi|111307761|gb|AAI21193.1

224.14

trans‐sialidase, putative

gi|49115532|gb|AAH73439.1

191.43

Clathrin heavy chain

gi|47939759|gb|AAH72193.1

178.62

Topoisomerase II

gi|89514893|gb|AAV35204.2

162.57

fanconia anemia complementation group D2

gi|38173761|gb|AAH60753.1

138.84

Collagen alpha 1(III) chain precursor isoform

gi|47122916|gb|AAH70581.1

131.69

Transcription termination factor 2 (RNA
polymerase II termination factor)

gi|49899007|gb|AAH76715.1

122.08

ISWI

gi|50418010|gb|AAH77918.1

104.17

Actinin, alpha 4

gi|108935850|sp|P55861

100.26

MCM2

gi|1621291|gb|AAC60033.1

99.97

ORC1

gi|1002598|gb|AAB01680.1

97.18

Cdc21/MCM4

gi|109940097|sp|P30664

97.12

MCM4‐B

gi|82231283|sp|Q5FWY4

92.64

MCM6

gi|109940096|sp|P49739

90.41

MCM‐3

gi|868012|dbj|BAA07268.1

90.2

DNA replication licensing; Budding yeast
MCM3 and mammalian P1 protein homolog

gi|1469526|gb|AAB17253.1

81.88

MCM‐7

gi|82241532|sp|Q7ZXB1

81.73

MCM‐7B

gi|27735471|gb|AAH41312.1

81.03

ORC3‐like

gi|1753195|dbj|BAA09949.1

80.38

CDC46 MCM

gi|54261462|gb|AAH84208.1

79.83

epithelial protein lost in neoplasm beta
isoform 5; LIM domain and actin binding 1

gi|136655|sp|P25979

79.17

upstream binding factor

gi|2749954|gb|AAC60340.1

74.24

DNA‐PK

gi|27371247|gb|AAH41201.1

71.19

Heat shock 70 kD protein 8

gi|22653657|sp|Q8UVR5

70.21

ACF bromodomain

gi|68533794|gb|AAH99057.1

69.06

T‐SNARE domain containing 1

gi|32766481|gb|AAH54976.1

68.51

ubiquitin

gi|49119345|gb|AAH73454.1

63.77

cortactin Src substrate

gi|2947303|gb|AAC05382.1

62.88

thymopoietin, lamina‐associated
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I.1 Chromatin‐binding proteins found in Interphase, continued
Accession numbers

kD

Gene description

gi|80477560|gb|AAI08503.1

61.68

similar to Ariadne‐1 protein homolog (ARI‐1)
(Ubiquitin‐conjugating enzyme E2‐binding
protein 1) (UbcH7‐binding protein)

gi|28278602|gb|AAH44116.1

56.06

keratin

gi|125112|sp|P08776

55.68

keratin

gi|125106|sp|P16878

55.45

keratin

gi|66910686|gb|AAH97521.1

51.96

origin recognition complex, subunit 5‐like

gi|47122943|gb|AAH70609.1

50.2

tubulin alpha

gi|401166|sp|P30883

49.82

tubulin beta

gi|68533761|gb|AAH99014.1

48.09

DNA repair protein RAD52 homolog

gi|47939824|gb|AAH72305.1

47.47

keratin

gi|29126978|gb|AAH47983.1

47.29

ARP3 actin‐related protein 3 homolog

gi|47682287|gb|AAH70682.1

45.35

keratin

gi|27696928|gb|AAH43992.1

44.66

ARP2 actin‐related protein 2‐like

gi|27924422|gb|AAH45004.1

42.75

ubiquitin

gi|1703123|sp|P53505

41.85

actin

gi|80477601|gb|AAI08544.1

41.8

actin

gi|41016788|sp|O93400

41.77

actin

gi|27371277|gb|AAH41267.1

41.57

actin related protein 2/3 complex, subunit 1A

gi|27924181|gb|AAH44969.1

35.3

zinc‐finger protein NOA 36

gi|47506888|gb|AAH70989.1

34.34

actin related protein 2/3 complex, subunit 2,
34kDa

gi|49117926|gb|AAH72853.1

32.9

F‐actin capping protein alpha‐2 subunit
(CapZ alpha‐2)

gi|27370869|gb|AAH41233.1

30.65

actin capping protein beta subunit, isoform 2;
capZ

gi|54035281|gb|AAH84065.1

30.41

linker histone B4

gi|77748204|gb|AAI06701.1

29.66

ribosomal protein s4 x linked

gi|115594|sp|P25229

29.43

Actin‐binding protein chain A

gi|114795|sp|P15308

29.31

B4

gi|45360795|ref|NP_989071.1

28.04

proteasome subunit

gi|47937622|gb|AAH72203.1

27.65

Novel glutathione S‐transferase theta protein

gi|54261501|gb|AAH84423.1

27.34

proteasome (prosome macropain) subunit
alpha type 6

gi|66910988|gb|AAH97923.1

27.19

similar to Developmental pluripotency
associated 2 (Vespera)
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I.1 Chromatin‐binding proteins found in Interphase, continued
Accession numbers

kD

Gene description

gi|232034|sp|P30151

25.18

EF‐1‐beta

gi|32450305|gb|AAH54309.1

25.07

peroxiredoxin 6 isoform 2

gi|51338726|sp|P52301

24.4

Ran

gi|27735390|gb|AAH41293.1

24.34

GTP‐binding nuclear protein Ran (GTPase
Ran) (Ras‐like protein TC4)

gi|28436776|gb|AAH46569.1

24.06

ribosomal protein L15

gi|33416674|gb|AAH56034.1

20.6

ARP2/3 complex 21 kD subunit (p21‐ARC)

gi|33416674|gb|AAH56034.1

20.6

Arpc3

gi|44968390|gb|AAS49590.1

20.34

ribosomal protein L13

gi|52345592|ref|NP_001004844.
1

19.69

actin related protein 2/3 complex, subunit 4

gi|2118960|pir||I51568

18.8

ubiquitin

gi|27807503|ref|NP_777203.1

17.96

ubiquitin

gi|50414831|gb|AAH77328.1

17.14

Arpc5

gi|34785262|gb|AAH56660.1

14.86

Histone H2A.x or H2A

gi|4507761|ref|NP_003324.1

14.73

ubiquitin

gi|52346108|ref|NP_001005097.
1

13.49

Histone H2A.Z‐like

gi|52345610|ref|NP_001004853.
1

10.71

SUMO

gi|51701919|sp|P63049

8.56

ubiquitin
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I.2 Chromatin‐binding proteins found in Metaphase
Accession numbers

kD

Gene description

gi|49115532|gb|AAH73439.1
gi|47939759|gb|AAH72193.1
gi|28881882|dbj|BAC65235.1
gi|89514893|gb|AAV35204.2
gi|49118127|gb|AAH73087.1
gi|30172983|sp|Q9YHY6
gi|1722855|sp|P50532
gi|1722856|sp|P50533
gi|37748213|gb|AAH59308.1
gi|28277299|gb|AAH44276.1
gi|49899007|gb|AAH76715.1
gi|11874759|dbj|BAB19357.1

191.43
178.62
169.17
162.57
161.13
154.19
146.99
136.34
130.09
129.51
122.08
117.97

gi|71681279|gb|AAI00246.1

106.53

gi|2231169|gb|AAC60223.1
gi|1621291|gb|AAC60033.1
gi|52430485|gb|AAH82952.1
gi|109940097|sp|P30664

100.26
99.97
97.89
97.12

gi|48734665|gb|AAH72348.1

94.49

gi|82231283|sp|Q5FWY4
gi|868012|dbj|BAA07268.1
gi|54038573|gb|AAH84223.1
gi|50603918|gb|AAH77195.1
gi|6016534|sp|P55862

92.64
90.2
84.24
82.96
82.44

gi|27503844|gb|AAH42232.1

82.03

gi|65265|emb|CAA42523.1
gi|1469526|gb|AAB17253.1
gi|136655|sp|P25979
gi|14330668|emb|CAC41092.1
gi|49118978|gb|AAH73609.1

82.01
81.88
79.17
74.97
74.53

clathrin, heavy polypeptide
topoisomerase II
topoisomerase II binding protein topBP1
Fanconi anemia complementation group D2
werner helicase
condensin XCAP‐D2
SMC‐4
SMC‐2
pyruvate carboxylase isoform 2
topoisomerase II
ISWI
ubiquitin‐activating enzyme E1
SWI/SNF‐related matrix‐associated actin‐
dependent regulator of chromatin a‐like 1
(HARP)
MCM‐2
ORC‐1
glycogen phosphorylase
mcm4
Loss of heterozygosity 11 chromosomal region 2
gene A protein homolog (Mast cell surface
antigen 1) (Masa‐1)
mcm6
mcm3
DNA repair protein RAD50
hsp90
mcm5
Nucleolar transcription factor 1‐B (Upstream‐
binding factor 1‐B)
upstream binding factor
MCM7
nucleolar transcription factor 1A
HIRA
SRP

gi|50417653|gb|AAH77757.1

72.67

Heat shock 70 kD protein 5
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I.2 Chromatin‐binding proteins found in Metaphase, continued
Accession numbers

kD

Gene description

gi|27371247|gb|AAH41201.1

71.19

hsp70

gi|28374367|gb|AAH46262.1

70.79

Hsc70 protein

gi|22653657|sp|Q8UVR5

70.21

ACF

gi|4630797|dbj|BAA76953.1

69.28

ku70

gi|68533794|gb|AAH99057.1

69.06

T‐SNARE domain containing 1

gi|32766481|gb|AAH54976.1

68.51

ubiquitin

gi|49118613|gb|AAH73637.1

68.33

novel protein similar to guanylate binding
protein 4

gi|8515825|gb|AAF76194.1

67.45

transketolase

gi|400975|sp|Q01588

67.09

RPA p70

gi|47122884|gb|AAH70559.1

66.9

RPA

gi|12230782|sp|Q9W7F2

66.09

WD repeat actin interacting

gi|48734658|gb|AAH72321.1

64.33

5‐aminoimidazole‐4‐carboxamide
ribonucleotide formyltransferase/IMP
cyclohydrolase

gi|54038187|gb|AAH84353.1

62.83

ORC2

gi|49115344|gb|AAH73315.1

62.11

glucose phosphate isomerase

gi|13111394|dbj|BAB32829.1

59.94

keratin

gi|27924333|gb|AAH44997.1

59.59

Chaperonin containing TCP1, subunit 5

gi|2497536|sp|Q92122

57.53

pyruvate kinase

gi|28278602|gb|AAH44116.1

56.06

keratin

gi|125106|sp|P16878

55.45

keratin

gi|51895961|gb|AAH81233.1

53.7

Dihydrolipoyllysine‐residue
Dihydrolipoamide branched chain
transacylase (BCKAD E2)

gi|66910686|gb|AAH97521.1

51.96

origin recognition complex, subunit 5‐like

gi|119140|sp|P17508

50.2

elongation factor 1

gi|54648594|gb|AAH84938.1

50.07

tubulin, alpha 2

gi|401166|sp|P30883

49.82

tubulin

gi|68533761|gb|AAH99014.1

48.09

similar to DNA repair protein RAD52
homolog

gi|32766495|gb|AAH54993.1

48

gi|33585662|gb|AAH56110.1

47.62

glutamic‐oxaloacetic transaminase 2,
mitochondrial (aspartate aminotransferase 2);
Got2

gi|27371000|gb|AAH41279.1

47.46

Alpha‐enolase (2‐phosphoglycerate
dehydratase)

keratin
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I.2 Chromatin‐binding proteins found in Metaphase, continued
Accession numbers

kD

Gene description

gi|27924422|gb|AAH45004.1

42.75

ubiquitin

gi|27924422|gb|AAH45004.1

42.75

ubiquitin

gi|47124885|gb|AAH70578.1

42.73

hyaluronan binding protein 4

gi|54038179|gb|AAH84215.1

41.97

dual specificity phosphatase 6

gi|1703123|sp|P53505

41.85

actin

gi|41016788|sp|O93400

41.77

actin

gi|50414850|gb|AAH77339.1

41.74

aurora B

gi|76780024|gb|AAI06623.1

39.41

aldolase

gi|1944025|dbj|BAA19524.1

39.39

aldolase

gi|3928511|dbj|BAA34671.1

39.27

aldolase

gi|125504|sp|P12965

39.16

Serine/threonine‐protein kinase mos (pp39‐
mos)

gi|82186776|sp|Q6PAB3

36.43

malate dehydrogenase

gi|50415703|gb|AAH77642.1

36.23

annexin A5

gi|50882324|gb|AAT85637.1

35.79

malate dehydrogenase

gi|1016758|gb|AAA91456.1

35.5

transcription factor A; HMG box
mitochondrial transcription factor

gi|6680047|ref|NP_032169.1

35.08

guanine nucleotide binding protein (G
protein), beta polypeptide 2 like 1

gi|132983|sp|P15125

34.11

60S ribosomal protein L5‐A

gi|51593227|gb|AAH78560.1

31.7

esterase D/formylglutathione hydrolase isoform 3

gi|54035281|gb|AAH84065.1

30.41

B4

gi|33417132|gb|AAH56066.1

30.27

ribosomal protein S2

gi|82210070|sp|Q801S3

29.94

40S ribosomal protein S3a

gi|49255981|gb|AAH72834.1

29.87

60S ribosomal protein L7a

gi|49255981|gb|AAH72834.1

29.87

similar to 60S ribosomal protein L7a

gi|77748204|gb|AAI06701.1

29.66

ribosomal protein s4 x linked

gi|90120317|sp|P49401

29.65

40S ribosomal protein S4

gi|48734630|gb|AAH72101.1

29.45

RPA

gi|9789803|sp|Q9YGP6

28.9

histone RNA stem‐loop‐binding protein2

gi|7248365|dbj|BAA92700.1

28.81

PCNA

gi|47937622|gb|AAH72203.1

27.65

Glutathione S‐transferase theta 1

gi|66910988|gb|AAH97923.1

27.19

developmental pluripotency associated 2,
isoform CRA_b (Vespera)

gi|28461382|gb|AAH46864.1

26.76

triosephosphate isomerase 1

gi|32484222|gb|AAH54171.1

25.39

glutathione S‐transferase M1

115

I.2 Chromatin‐binding proteins found in Metaphase, continued
Accession numbers

kD

Gene description

gi|51338726|sp|P52301

24.4

Ran

gi|33417168|gb|AAH56115.1

24.27

unknown protein, might have homology to
similar to Tumor necrosis factor receptor

gi|32450087|gb|AAH53774.1

22.74

glutathione s‐transferase

gi|27735416|gb|AAH41242.1

22.58

Ribosomal protein S9

gi|48734656|gb|AAH72318.1

22.44

peroxiredoxin 2

gi|134026|sp|P02362

22.18

ribosomal S7

gi|62185728|gb|AAH92331.1

21.69

Sorcin

gi|50604065|gb|AAH77192.1

21.4

60S ribosomal protein L17

gi|27882415|gb|AAH44685.1

20.92

Ferritin heavy chain, oocyte isoform (A‐
ferritin)

gi|27769162|gb|AAH42256.1

20.78

ribosomal protein L18a

gi|51873961|gb|AAH78513.1

20.18

ribosomal protein L11

gi|929913|emb|CAA24703.1

19.46

ribosomal protein S8

gi|1168995|sp|P45593

19.12

cofilin

gi|585934|sp|Q07254

18.88

40S ribosomal protein S10

gi|2118960|pir|

18.8

ubiquitin

gi|49255998|gb|AAH73305.1

18.66

Ribosomal protein L21

gi|49255998|gb|AAH73305.1

18.66

60S ribosomal protein L23a

gi|730626|sp|P41115

18.42

ribosomal

gi|27807503|ref|NP_777203.1

17.96

ubiquitin

gi|52346118|ref|NP_001005104.
1

17.19

ribosomal

gi|4507761|ref|NP_003324.1

14.73

ubiquitin

gi|16974922|pdb|1K5J

13.74

nucleoplasmin

gi|49256565|gb|AAH72995.1

10.87

smt3

gi|51701919|sp|P63049

8.56

ubiquitin

116

I.3 Background proteins that bind to streptavidin‐beads
Accession numbers

kD

Gene description

gi|111307761|gb|AAI21193.1

224.14

trans‐sialidase

gi|28422180|gb|AAH46866.1|

214.69

chromodomain helicase DNA binding protein 4

gi|12057014|emb|CAC19793.1|

190.13

53BP1 protein

gi|47939759|gb|AAH72193.1

178.62

topoisomerase (DNA) II alpha

gi|29387027|gb|AAH48220.1

170.24

plectin 1

gi|50927228|gb|AAH79780.1

164.81

Microtubule‐associated serine/threonine‐protein
kinase 3

gi|54648598|gb|AAH84946.1|

160.3

polybromo 1

gi|1722855|sp|P50532|SMC4_XE
NLA

146.99

Structural maintenance of chromosome 4
(Chromosome‐associated protein C)
(Chromosome assembly protein XCAP‐C)

gi|49522205|gb|AAH74479.1

145.8

flightless I homolog

gi|49115497|gb|AAH73405.1

141.58

Apoptotic protease activating factor 1 (Apaf‐1)

gi|49115413|gb|AAH73356.1

137.94

DNA mismatch repair protein Mlh3 (MutL
protein homolog 3)

gi|55250671|gb|AAH86289.1

136.88

androgen‐induced prostate proliferative shutoff
associated

gi|37748213|gb|AAH59308.1

130.09

Pyruvate carboxylase

gi|37748213|gb|AAH59308.1

130.09

Pyruvate carboxylase, mitochondrial precursor

gi|39645073|gb|AAH63719.1

124.66

Nuclear receptor‐interacting protein 1 (Nuclear
factor RIP140)

gi|71052228|gb|AAH98986.1

122.56

ubiquitination factor E4A

gi|50415131|gb|AAH77364.1

120.68

vacuolar protein sorting 13A isoform A

gi|49118072|gb|AAH73023.1

119.13

Bub1b protein

gi|29165659|gb|AAH49176.1

115.4

Atp12a‐prov

gi|82243533|sp|Q8JI28|TLL1_XE
NLA

114.37

Tolloid‐like protein 1 precursor (Xenopus tolloid‐
like protein 1) (Metalloprotease xolloid‐like) (Xlr)

gi|51895934|gb|AAH81001.1

111.5

cis‐Golgi matrix protein GM130

gi|46250354|gb|AAH68936.1

109.64

Ext2‐prov protein

gi|54648511|gb|AAH85055.1

109.59

alanyl (membrane) aminopeptidase

gi|47506906|gb|AAH70993.1

104.47

DNA ligase III isoform alpha

gi|47124802|gb|AAH70795.1

103.08

M‐phase phosphoprotein 1

gi|47124776|gb|AAH70757.1

101.9

exosome component 10

gi|28422362|gb|AAH46949.1

101.05

transportin 2

gi|80476351|gb|AAI08521.1

99.69

Mycbp associated protein

gi|46249663|gb|AAH68957.1

99.31

similar to proteasome 26S non‐ATPase subunit 2

gi|38014398|gb|AAH60445.1

97.89

glycogen phosphorylase
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I.3 Background proteins that bind to streptavidin‐beads, continued
Accession numbers

kD

Gene description

gi|60688087|gb|AAH91631.1

96.29

3‐hydroxy‐3‐methylglutaryl‐coenzyme
A reductase (HMG‐CoA reductase)

gi|50927226|gb|AAH79778.1

95.51

Ubiquitin specific peptidase 5
(isopeptidase T)

gi|27882475|gb|AAH44327.1

95.43

Eef2‐prov protein

gi|28422362|gb|AAH46949.1

89.21

Vcp‐prov

gi|28422362|gb|AAH46949.1

89.21

Vcp‐prov

gi|50414847|gb|AAH77338.1

85.48

eukaryotic translation initiation factor
4E nuclear import factor 1

gi|82235865|sp|Q6DFJ6|TBK1

83.27

Serine/threonine‐protein kinase TBK1

gi|50603918|gb|AAH77195.1

82.96

Hsp90beta protein

gi|27881752|gb|AAH44703.1|

82.08

Complement factor I

gi|228024|prf||1715211A

82

ribosomal transcription factor xUBF2

gi|52430485|gb|AAH82952.1

81.73

DNA replication licensing factor
mcm7‐B

gi|56270045|gb|AAH87496.1

80.56

Leucine‐rich repeat and fibronectin
type‐III domain‐containing protein 2

gi|54035194|gb|AAH84059.1

80.5

gelsolin

gi|49116037|gb|AAH73703.1|

79.33

discoidin, CUB and LCCL domain
containing 1

gi|59862015|gb|AAH90253.1

78.45

Propionyl‐Coenzyme A carboxylase

gi|50414914|gb|AAH77828.1

77.18

dsRNA‐binding protein 4F.1

gi|54647570|gb|AAH84933.1

76.3

Leucine zipper, putative tumor
suppressor 2

gi|5421757|dbj|BAA82338.1

75.21

Tbx2

gi|28302215|gb|AAH46732.1|

74.99

Stau2‐a

gi|66912037|gb|AAH97633.1

74.05

Arginyl‐tRNA synthetase, cytoplasmic

gi|57921040|gb|AAH89141.1

72.64

centrosomal protein 70 kD

gi|46250301|gb|AAH68696.1|

72.29

Hsl7 protein

gi|27371247|gb|AAH41201.1

71.19

Heat shock 70 kD

gi|27371247|gb|AAH41201.1

71.19

Hsc70 protein

gi|213926|gb|AAA02822.1

71.01

LReO_3

gi|28374367|gb|AAH46262.1

70.79

Hsc70 protein

gi|28374367|gb|AAH46262.1

70.79

Hsc70 protein

gi|13540314|gb|AAK29408.1|AF338225
_1

70.72

embryonic poly(A) binding protein
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I.3 Background proteins that bind to streptavidin‐beads, continued
Accession numbers

kD

Gene description

gi|54038353|gb|AAH84637.1

70.46

similar to breast cancer anti‐estrogen
resistance 1

gi|115528349|gb|AAI24971.1

70.37

unknown

gi|47718038|gb|AAH70981.1

69.31

FUSE binding protein‐like protein

gi|50604152|gb|AAH77445.1

69.27

Ku70

gi|47940320|gb|AAH72359.1

68.53

novel protein

gi|32766481|gb|AAH54976.1

68.51

Ubc‐prov

gi|49118613|gb|AAH73637.1

68.33

guanylate binding protein 4

gi|63100234|gb|AAH95915.1

64.99

extracellular signal‐regulated kinase 7

gi|49115557|gb|AAH73457.1

64.96

Fragile X mental retardation syndrome‐
related protein 1

gi|50414890|gb|AAH77811.1

64.81

Nars‐prov

gi|48734658|gb|AAH72321.1

64.33

5‐aminoimidazole‐4‐carboxamide
ribonucleotide formyltransferase/IMP
cyclohydrolase

gi|110278982|sp|Q2KHP9|FMR1B

63.86

Fragile X mental retardation protein 1 homolog‐B

gi|49114811|gb|AAH72755.1

62.02

mannosyl (alpha‐1,3‐)‐glycoprotein beta‐1,4‐
N‐acetylglucosaminyltransferase, isoenzyme
A isoform 2

gi|54035212|gb|AAH84097.1

61.48

YTH domain family, member 1

gi|51258451|gb|AAH80087.1

60.97

Synaptotagmin‐14 (Synaptotagmin XIV)
(SytXIV)

gi|115528345|gb|AAI24968.1

60.83

unknown

gi|27696390|gb|AAH43885.1

60.36

Tn3 protein

gi|52139070|gb|AAH82625.1

60.35

tyrosine phosphatase Cdc25A

gi|50418025|gb|AAH77347.1

60.31

golgin 97

gi|37748655|gb|AAH59999.1

60.14

disabled homolog 2

gi|13111394|dbj|BAB32829.1

59.94

larval keratin XLK

gi|83318223|gb|AAI08628.1

59.68

Transcription intermediary factor 1‐gamma
(TIF1‐gamma) (Tripartite motif‐containing
protein 33)

gi|49115856|gb|AAH73593.1

57.47

proteasome 26S non‐ATPase subunit 3

gi|50925193|gb|AAH79694.1

57.32

hydroxymethylglutaryl‐CoA synthase

gi|27694844|gb|AAH44037.1

57.24

DnaJ (Hsp40) homolog, subfamily C,
member 3

gi|51703900|gb|AAH81073.1

56.94

M‐phase phosphoprotein 1

gi|28278602|gb|AAH44116.1

56.06

Krt8‐prov
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I.3 Background proteins that bind to streptavidin‐beads, continued
Accession numbers

kD

Gene description

gi|125112|sp|P08776|K2C8

55.68

Keratin, type II cytoskeletal 8

gi|125106|sp|P16878|K2C5

55.45

Keratin, type II cytoskeletal

gi|58402678|gb|AAH89255.1

55.11

Protein C6orf182

gi|55953148|dbj|BAD72829.1|

54.76

transcription factor Glial cells missing‐2

gi|1709533|sp|P54824|DDX6

54.09

Probable ATP‐dependent RNA helicase
DDX6

gi|50415415|gb|AAH78086.1

54

annexin VII

gi|50415415|gb|AAH78086.1

54

annexin VII

gi|50415295|gb|AAH77476.1

53.27

Ina‐A‐prov

gi|50415295|gb|AAH77476.1

53.27

Ina‐A‐prov protein

gi|115528666|gb|AAI24898.1

53.21

unknown

gi|26106079|dbj|BAC41520.1

51.9

adult keratin XAK‐C

gi|47124798|gb|AAH70789.1

51.75

similar to R3H domain (binds single‐
stranded nucleic acids) isoform 2

gi|76780035|gb|AAI06644.1

50.49

FGFR1 oncogene partner

gi|67678009|gb|AAH97795.1

50.27

Nucleoporin‐like 2

gi|62471477|gb|AAH93575.1

50.05

galactosidase, beta 1‐like

gi|27735425|gb|AAH41186.1

49.85

proteasome (prosome, macropain) 26S
subunit, ATPase 2

gi|50417476|gb|AAH77344.1

49.47

adaptor‐related protein complex 4, mu
1 subunit

gi|32484378|gb|AAH54287.1

49.15

proteasome (prosome, macropain) 26S
subunit, ATPase, 1

gi|3024672|sp|Q91604|STK11_XENL
A

49.07

Serine/threonine‐protein kinase 11

gi|33585662|gb|AAH56110.1

47.62

Got2‐prov protein

gi|37994750|gb|AAH60362.1

47.39

Psmc4

gi|785052|emb|CAA60136.1|

47.25

POU‐60

gi|27371295|gb|AAH41276.1

47.17

phosphoribosylaminoimidazole
carboxylase

gi|49255977|gb|AAH72829.1

46.52

proteasomal ATPase (SUG1)

gi|66912074|gb|AAH97800.1

46.19

Stromal membrane‐associated protein
1‐like

gi|52139072|gb|AAH82626.1

45.77

Solute carrier family 30 (zinc
transporter), member 4
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I.3 Background proteins that bind to streptavidin‐beads, continued
Accession numbers

kD

Gene description

gi|58702032|gb|AAH90247.1

45.75

CG12822‐PA

gi|54038456|gb|AAH84351.1

45.56

proteasome (prosome, macropain) 26S
subunit, non‐ATPase, 6

gi|22000680|gb|AAM88215.1|AF468029
_1

45.29

IAP‐like protein

gi|27696928|gb|AAH43992.1

44.66

Similar to ARP2 actin‐related protein 2
homolog

gi|49258183|gb|AAH73644.1|

44.58

Psmc6 protein

gi|50416416|gb|AAH77781.1|

44.58

Pgk2‐prov

gi|46249540|gb|AAH68755.1

44.13

mitochondrial acetoacetyl‐CoA
thiolase

gi|50414512|gb|AAH77742.1

43.99

nexin‐1

gi|6138954|gb|AAF04406.1|AF057166_
1

43.52

gag‐like protein

gi|56269237|gb|AAH87502.1

43.39

galactose‐1‐phosphate
uridylyltransferase

gi|76780144|gb|AAI06431.1

42.98

keratin 18

gi|51261513|gb|AAH80105.1

42.98

TIA1 cytotoxic granule‐associated
RNA binding protein

gi|27924422|gb|AAH45004.1

42.75

UBC protein

gi|27924422|gb|AAH45004.1

42.75

UBC

gi|27924422|gb|AAH45004.1

42.75

ubiquitin C

gi|4902905|emb|CAB43617.1

42.05

Actin

gi|32450257|gb|AAH54262.1

41.88

Actin, alpha sarcomeric/skeletal

gi|71679779|gb|AAI00175.1

41.87

FAM61B

gi|1703127|sp|P53506|ACT8

41.85

Actin, cytoplasmic type 8

gi|76779973|gb|AAI06448.1

41.69

family 53, member C protein

gi|76779973|gb|AAI06448.1

41.69

similar to family 53, member C protein

gi|12003372|gb|AAG43543.1|AF212298
_1

40.93

septin A

gi|1944025|dbj|BAA19524.1

39.39

aldolase

gi|47124806|gb|AAH70798.1

39.32

similar to cyclin fold protein 1

gi|50418209|gb|AAH77241.1

38.6

Protein KIAA0174

gi|56270048|gb|AAH87497.1

38.58

Cyclin N‐terminal domain containing
1
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I.3 Background proteins that bind to streptavidin‐beads, continued
Accession numbers

kD

Gene description

gi|56270048|gb|AAH87497.1

38.58

similar to Serine/threonine‐protein
kinase WNK4 (Protein kinase with no
lysine 4) (Protein kinase, lysine‐deficient
4) (Liver regeneration‐related protein
LRRG120)

gi|52139097|gb|AAH82713.1

37.93

cdc25 protein

gi|115292033|gb|AAI22496.1

37.77

unknown

gi|27371273|gb|AAH41257.1

37.52

Ags3‐prov protein

gi|27371273|gb|AAH41257.1

37.52

Ags3‐prov protein

gi|214157|gb|AAA49716.1

37.23

Y‐box‐binding protein 2‐B

gi|51703920|gb|AAH81139.1

36.61

Psmd7 protein

gi|57032700|gb|AAH88936.1

36.54

fubp1

gi|82186776|sp|Q6PAB3|MDHC

36.43

Malate dehydrogenase, cytoplasmic

gi|2498255|sp|Q91653|CRHBP

36.29

Corticotropin‐releasing factor‐binding
protein precursor

gi|55250533|gb|AAH86269.1

36.01

ELAV (embryonic lethal, abnormal
vision, Drosophila)‐like 1 (Hu antigen
R)

gi|50882324|gb|AAT85637.1

35.79

mitochondrial malate dehydrogenase 2a

gi|49255952|gb|AAH71073.1|

35.71

mitochondrial malate dehydrogenase 2b

gi|50925082|gb|AAH79812.1

35.33

Solute carrier family 25 member 44

gi|38540890|gb|AAH61930.1|

34.86

ubiquitin fusion degradation 1‐like

gi|27924246|gb|AAH45094.1

34.57

Psmd14‐prov protein

gi|71682415|gb|AAI00234.1

33.46

fused toes homolog

gi|3334381|sp|Q91836|TRBP_XENL
A

32.85

Double‐stranded RNA‐binding protein
A (XlRBPA)

gi|3334381|sp|Q91836|TRBP_XENL
A

32.85

Double‐stranded RNA‐binding protein
A

gi|76779636|gb|AAI06582.1

32.36

Valacyclovir hydrolase precursor
(VACVase) (Biphenyl hydrolase‐like
protein) (Biphenyl hydrolase‐related
protein) (Bph‐rp)

gi|47940223|gb|AAH72042.1

32.1

DnaJ (Hsp40) homolog,

gi|50603800|gb|AAH77738.1

31.56

Pura‐prov protein
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I.3 Background proteins that bind to streptavidin‐beads, continued
Accession numbers

kD

Gene description

gi|46329485|gb|AAH68763.1

30.98

Proteasome (prosome, macropain)
26S subunit, non‐ATPase, 8

gi|32450017|gb|AAH54141.1

30.48

Drng‐A‐prov

gi|82210070|sp|Q801S3|RS3A_XENLA

29.94

40S ribosomal protein S3a

gi|34849610|gb|AAH58201.1

28.44

Psma3‐prov protein

gi|27884299|dbj|BAC55886.1

28.33

galectin family galectin‐VIIa

gi|45360795|ref|NP_989071.1

28.04

proteasome (prosome, macropain)
subunit, alpha type 7

gi|12229929|sp|Q9PVQ1|PSA7B_XENLA

27.94

Proteasome subunit alpha type 7‐B
(Proteasome subunit alpha 4‐B)

gi|49257961|gb|AAH71115.1

27.48

Myeloid leukemia factor 2

gi|50603942|gb|AAH77442.1

27.46

Psma6‐prov protein

gi|54038683|gb|AAH84334.1

27.11

DnaJ homolog subfamily B member
6

gi|27697097|gb|AAH43976.1

26.43

Rpl13a‐prov protein

gi|54035222|gb|AAH84116.1

26.17

ubiquitin carboxyl‐terminal esterase

gi|62858493|ref|NP_001016382.1

25.83

Psma2 protein

gi|28422711|gb|AAH46936.1

25.49

Dnajb9‐prov protein

gi|77748321|gb|AAI06643.1

24.86

Ubiquitin carboxyl‐terminal esterase
L1 (ubiquitin thiolesterase)

gi|57921028|gb|AAH89136.1

24.61

eIF‐4E protein

gi|49256355|gb|AAH74452.1

24.36

tissue inhibitor of mettaloproteinase
2

gi|73535301|pdb|1U20|A

24.35

Nudix Hydrolase Nuclear Snorna
Decapping Protein X29

gi|49114954|gb|AAH72812.1

24.03

Seb4‐A‐prov

gi|56270462|gb|AAH87395.1

23.04

proteasome (prosome, macropain)
subunit, beta type 3

gi|32450087|gb|AAH53774.1|

22.74

XlGSTS1‐1 protein

gi|49119183|gb|AAH72908.1

22.61

proteasome (prosome macropain)
subunit beta type 2

gi|52138931|gb|AAH82679.1

22.55

within bgcn homolog

gi|48734656|gb|AAH72318.1|

22.44

peroxiredoxin 2

gi|134026|sp|P02362|RS7_XENLA

22.18

40S ribosomal protein S7 (S8)

gi|13124486|sp|Q9YGP5|RBPMS_XENL
A

21.68

RNA‐binding protein with multiple
splicing homolog (RBP‐MS) (Heart,
RRM Expressed Sequence) (Hermes)
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I.3 Background proteins that bind to streptavidin‐beads, continued
Accession numbers

kD

Gene description

gi|49256167|gb|AAH73601.1

19.92

40S ribosomal protein S10

gi|32450483|gb|AAH53796.1

18.86

signal sequence receptor delta

gi|2118960|pir||I51568

18.8

polyubiquitin

gi|27807503|ref|NP_777203.1

17.96

ribosomal protein S27a

gi|51873786|gb|AAH78526.1

17.67

similar to 60S ribosomal protein L23a

gi|6225751|sp|P70010|NDKA1_XENLA

17.49

Nucleoside diphosphate kinase A1
(NDK A1) (NDP kinase A1)
(NM23/nucleoside diphosphate kinase
A1)

gi|82180497|sp|Q5XHI2|K1143

17.14

KIAA1143

gi|54647585|gb|AAH84940.1|

14.76

myeloid leukemia factor 2

gi|4507761|ref|NP_003324.1

14.73

ubiquitin and ribosomal protein L40
precursor

gi|51701919|sp|P63049|UBIQ_CANFA

8.56

Ubiquitin

gi|998831|gb|AAB34537.1

2.9

Tyrosine kinase catalytic domain, clone
Xltk27
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MATERIAL AND METHODS

Antibodies
Vespera antibodies were raised in rabbits against full‐length recombinant
Vespera protein.

PP1α antibodies were raised against the C‐terminal

peptide CPTVTPPRGMITKQAKK (a gift of J. Rosenberg). Antibodies were
affinity‐purified after coupling of the protein antigen to SulfoLink Coupling
Gel (Pierce) according to the manufacturer’s instructions. Bound antibodies
were eluted with 100mM glycine (pH 2.3) into neutralizing Tris base, and
peak fractions were pooled and dialyzed serially against PBS/50% glycerol,
PBS, and PBS/50% glycerol. Affinity‐purified antibodies were stored at ‐
20°C.

X. laevis Egg Extracts and Chromatin Bead Purification
Meiotic metaphase II‐arrested (CSF) Xenopus laevis egg extracts were
prepared as previously described (Murray, 1991).

DNA‐beads without

DNA ends were prepared from pBluescript SK+ plasmid as previously
described (Postow et al., 2008). Briefly, the plasmid was digested with
BamHI, and the overhangs were filled in with biotinylated nucleotides
using Klenow reaction (New England Biolabs, Inc.). The biotinylated DNA
was then coupled to streptavidin M280 Dynabeads (Invitrogen). Metaphase
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spindles were assembled in egg extracts around DNA‐beads, as described
(Heald et al., 1996). The metaphase chromatin beads were then collected on
a magnet in the presence of 10 μg/ml nocodazole, washed five times with
30SDB2+150 mM NaCl (10 mM Hepes, 150 mM NaCl, 10 mM β‐
glycerophosphate, 50 mM NaF, 20 mM EGTA, 2 mM EDTA, 0.5 mM
spermin, 30% sucrose, and 0.05% Triton X‐100), transferred to a new
Eppendorf tube, and proteins were eluted with SDS‐PAGE sample buffer .
Interphase chromatin beads were produced by incubation of DNA‐beads in
CSF extracts plus 0.3 mM calcium and 100 μg/ml cycloheximide for 80 min
at 22°C. To purify these beads, nuclear membranes we re first disrupted by
addition of 2.5 volumes of ice‐cold DB2+Triton (10 mM Hepes, 10 mM β‐
glycerophosphate, 50 mM NaF, 20 mM EGTA, 2 mM EDTA, 0.5 mM
spermin, 0.1% Triton X‐100) to the extracts containing beads, and incubation
for 10 min on ice.

This mixture was layered on top of 400 μL of

60SDB2+Triton (10 mM Hepes, 10 mM β‐glycerophosphate, 50 mM NaF, 20
mM EGTA, 2 mM EDTA, 0.5 mM spermin, 60% sucrose , 0.1% Triton X‐100)
and spun at 4000g for 10 min at 4°C in a centrifuge with a swinging bucket
rotor.

The sucrose interface was washed twice with DB2+Triton.

The

supernatant was removed, and the beads were collected on a magnet. The
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beads were then washed five times with DB2+Triton, placed in a fresh
Eppendorf tube, and proteins were eluted with SDS‐PAGE sample buffer.

Identification of Vespera SUMOylation
To identify the modification of Vespera, 35S‐labeled Vespera was translated
in vitro using a cDNA clone in pBluescript SK‐ (Open Biosystems) and a
coupled transcription‐translation system in rabbit reticulocyte lysate (T7
promoter, Promega). For each sample, 2 μL of labeled protein reaction was
added to 50 μL of CSF extract containing cycloheximide and nocodazole,
and incubated for 40 min at 22°C, along with 2 μL buffer (50 mM HEPES
pH 8.0, 150 mM NaCl, 1 mM DTT) or 50 μg/ml 6His‐SUMO‐1, 6His‐SUMO‐
2, 6His‐SUMO‐3 (Boston Biochem), or 6His‐Ubiquitin (Postow et al., 2008).
DNA‐beads (equivalent to 1 μg DNA) were then added to each sample and
incubated for an additional 40 min at 22°C, along with 7 μL of streptavidin‐
beads, to facilitate beads’ recovery. The beads were collected on a magnet,
washed five times with 30SDB2+150mM NaCl, transferred to a new
Eppendorf tube, and proteins were eluted with SDS‐PAGE sample buffer.
Proteins were separated by SDS‐PAGE, and the gel was dried and
visualized by autoradiography using a phosphorimager (Fujifilm).
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In vitro Translation and Mutational Analysis
To identify the SUMOylation site of Vespera, all thirteen of its lysine
residues were individually mutated to arginine. The resulting cDNA clones
were transcribed and translated in vitro to produce 35S‐labeled proteins.
Labeled proteins were added to extract, and analyzed for SUMOylation
using chromatin beads, as described above.

This analysis was also

conducted for the following phosphorylation site mutants: S183A; S183D;
S226A, S234A (double mutant); S226E, S234D (double mutant).

Protein Purification
Flag‐tagged wild‐type and mutant Vespera proteins were expressed as GST‐
fusions in BL21 bacteria from pGEX‐6P‐1 plasmid (GE Lifesciences).
Bacteria were grown to OD 0.6, induced with 0.5 mM IPTG for 7 h at 30°C,
and harvested by centrifugation. Bacterial pellets were resuspended in lysis
buffer (PBS, 1 mM DTT, 150 mM NaCl, 0.1% Triton‐X, protease inhibitors)
and lysed by sonication. The sonicates were treated with 1 mg/ml lysozyme
and 0.04 mg/ml DNase I for 15 min at room temperature. Insoluble material
was pelleted by centrifugation for 20 min at 16k rpm and 4°C in SS‐34 rotor
(Sorvall). Clarified lysates were incubated with glutathione‐sepharose 4b
(GE Lifesciences) to bind GST‐fusion proteins, and the resin was washed on
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a column with 1 L of PBS + 1 mM DTT and protease inhibitors. GST‐tagged
proteins were eluted with 2 column volumes of PBS+15mM glutathione,
and the GST tag was cleaved with Prescission Protease (GE Lifesciences) for
10‐16 h at 4°C. Simultaneously, the protein was dialyzed into PBS + 1 mM
DTT to remove glutathione.

Excess GST, Prescission Protease, and

nonspecific glutathione‐sepharose binding proteins were then removed by
an additional incubation with glutathione‐sepharose.

Immunodepletions
Egg extracts were immunodepleted using antibodies bound to Protein A‐
Dynabeads (Invitrogen). Prior to antibody binding, beads were washed
three times with TBS.

Antibody was then bound to beads at a final

concentration of 0.1 mg/ml (volume of beads slurry as provided by the
manufacturer), with incubation for 10‐30 min with rotation at room
temperature. Following binding, beads were again washed three times with
TBS, and stored for up to a week at 4°C. Before addition to extract, beads
were washed with Sperm Dilution Buffer (5 mM K‐HEPES [pH 7.7], 1mM
MgCl2, 100 mM KCl, 150 mM sucrose), and isolated, dry, on magnet. The
volume of beads was determined prior to buffer removal. For Vespera
depletion, ½ volume of beads were added to 1 volume of extract, for one

129

hour on ice. These beads were then collected on a magnet, and a second
round of depletion was carried out, identical to the first. For control and
Incenp depletions, this procedure was repeated using IgG beads and anti‐
Incenp beads, respectively. For Incenp and Vespera co‐depletion, ½ volume
each of anti‐Vespera and anti‐Incenp beads were added to extract in two
rounds. For PIASy depletion, the first depletion was carried out for 15 min
at room temperature, and the second depletion was for one hour on ice.

Immunofluorescence Microscopy
Chromatin structures produced in egg extracts were processed for
immunofluorescence as described (Funabiki and Murray, 2000). 20 μL of
extracts containing metaphase spindles or 10 μL of extracts containing
interphase nuclei (500/μL) were fixed and spun down on glass coverslips.
Affinity‐purified Vespera antibodies were used at 200 ng/ml in AbDil
(TBS/0.1% Triton X‐100 + 2% BSA) for 1 h. Phospho‐histone H3 (Ser10)
antibodies (Millipore) were used at 1 μg/ml in AbDil for 1 h. Binding was
visualized

with

Alexa

488‐conjugated

goat

anti‐rabbit

antibodies

(Invitrogen). DNA was counterstained with 0.25 μg/ml Hoechst in AbDil
and mounted in mounting medium (90% glycerol, 20mM Tris‐HCl [pH
8.8]).
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Nuclear Assembly Reactions and Nuclear Import Assay
Demembranated X. laevis sperm nuclei were added to egg extracts on ice,
then moved to 22°C. Nuclear assembly was initiated by the addition of 0.3
mM calcium chloride, either immediately after adding sperm, or after 45
min prior incubation of sperm in extract at 22°C. Nuclear import was
analyzed by the addition of 50 μg/ml green fluorescent protein tagged with
nuclear localization signal (GFP‐NLS)

Spindle Assembly Reactions
In a typical spindle assembly reaction, 0.3 mM calcium chloride was added
to 40 μL of CSF extract containing 500 sperm/μL, cycloheximide, and
rhodamine tubulin. This reaction was incubated for 80 min at 22°C to
permit sperm remodeling and the completion of interphase. An additional
40 μL of CSF was then added to induce metaphase, and this reaction was
incubated for 30‐60 min more for spindle formation. For excess Vespera
experiments, recombinant protein was added to a final concentration of 4.5
μM in extract, an estimated 10‐fold excess over the endogenous
concentration.
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Chromosome Biotinylation and Purification
Chromosomes were biotinylated and purified from control and Vespera‐
depleted extracts as previously described (Funabiki and Murray, 2000;
Sampath et al., 2004). Briefly, biotin was incorporated from biotin‐dUTP
during replication in interphase. After cycling to metaphase, chromosomes
were pelleted from the extract through a sucrose cushion and affinity
purified using streptavidin‐Dynabeads (Invitrogen). Beads were washed
with 30SDB2 (10 mM Hepes, 10 mM β ‐glycerophosphate, 50 mM NaF, 20
mM EGTA, 2 mM EDTA, 0.5 mM spermin, 30% sucrose, and 0.05% Triton
X‐100) and proteins were eluted with SDS‐PAGE sample buffer.

Western Blots
Immunoblots were blocked with PBS/4% nonfat dry milk for 15‐30 min at
RT or overnight at 4°C. Primary antibodies were diluted in AbDil at the
following concentrations: 5 μg/ml anti‐Vespera, 5 μg/ml anti‐xIncenp, 3
μg/ml anti‐Xkid, 5 μg/ml anti‐PP1 μg/ml anti‐phosphohistone‐H3S10
(Millipore), 1:1000 anti‐phosphohistone‐H3T3 (Cell Signaling), 0.2 μg/ml
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anti‐Op18 (a gift of R. Heald), 1 μg/ml anti‐PIASy antibody (a gift of Y.
Azuma).
For secondary antibodies, IRDye 680 goat anti‐rabbit IgG (Li‐Cor)
and IRDye 800CW goat anti‐mouse IgG (Li‐Cor) were diluted in PBS/4%
nonfat dry milk + 0.1% Tween‐20. The Odyssey Infrared Imaging System
(Li‐Cor) was used for detection.

Interphase and Metaphase Analysis of Vespera
Vespera modifications in interphase and metaphase in the absence of DNA
were examined by Western blotting with anti‐Vespera antibodies. After 30
min incubation at 22°C, total protein samples were collected from 20 μl CSF
extract (metaphase), CSF extract with 0.3 mM calcium (interphase), or CSF
extract with 0.3 mM calcium and the Cdk inhibitor purvalanol (1 μM,
Sigma). Vespera modifications on DNA in interphase and metaphase were
examined using 35S‐labeled protein bound to chromatin beads. In vitro
translated 35S‐labeled Vespera was incubated in 50 μl CSF extract
(metaphase) or CSF extract containing 0.3 mM calcium (interphase) for 40
min at 22°C. DNA‐beads (1 μg DNA equivalent) were then added to the
extract for another 40 min, along with 7

μl streptavidin‐Dynabeads to

facilitate beads’ recovery. The beads were collected on a magnet and
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washed, and the proteins were eluted by SDS sample buffer and analyzed
by SDS‐PAGE and autoradiography.

Immunoprecipitation of Vespera
Vespera was immunoprecipitated from 100 μl of CSF extract using 50 μl of
crosslinked anti‐Vespera beads. The beads were prepared as previously
described , using dimethyl pimelimidate (DMP) crosslinker (Pierce). Beads
were washed five times with 30SDB2+150 mM NaCl, transferred to a new
tube, and proteins were eluted by SDS‐PAGE sample buffer.

Sperm Centrosome Aster Analysis
Sperm nuclei and 0.3 mM calcium chloride were added to CSF extracts
containing rhodamine‐tubulin and incubated at 20°C. After 12 minutes,
asters were fixed and visualized by fluorescence microscopy. Aster intensity
was calculated using Metamorph software (Molecular Devices) by
measuring the integrated intensity of a circle surrounding the aster and
subtracting a background region in the same frame of equal dimensions.
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In‐gel Chemical Dephosphorylation
All peptides were produced by solid‐phase peptide synthesis.

Bovine

casein was purchased from Sigma. Peptides or proteins were separated and
immobilized in Tris‐glycine gels (Invitrogen) by SDS‐PAGE, followed by
fixation for at least ten minutes in 20% methanol/5% acetic acid solution.
Fixation was sufficient to visualize precipitated peptides within the gel
without the need to use stains. Protein bands were visualized by colloidal
Coomassie GelCode Blue stain (Pierce). Bands were excised from the gel
and destained in 400 μL 55% 100 mM ammonium bicarbonate/45%
acetonitrile. Gel slices were then dehydrated in 300 μL acetonitrile (HPLC‐
grade from Pierce) and dried in a Speedvac (Thermo Savant). The dry gel
slices were immersed in 70 μL 70% HF‐pyridine (Sigma) and incubated on
ice for one hour, then washed twice with 150 μL acetic acid and twice with
150 μL water. Washed gel slices were soaked in 300 μL 0.5M ammonium
bicarbonate to raise the pH to ~8.5 before digestion with trypsin or Glu‐C
(Roche).

Safety Considerations for Using Hydrofluoric Acid (HF)
Note that HF is an extremely corrosive substance and should be handled in
a fume hood with appropriate care, including use of a lab coat, nitrile gloves
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and safety goggles.

After use, the HF solution and pipet tips were

neutralized in calcium chloride solution prior to disposal.

Mass Spectrometric Identification of Proteins
To identify proteins associating with interphase and metaphase chromatin
beads, proteins were separated by SDS‐PAGE and the entire gel lane was
cut into 1 mM slices using a gel slicer (Brinkman Instruments, Inc.). A
comprehensive protocol for matrix‐assisted laser desorption ionization
(MALDI)

sample

preparation

is

available

online

at

http://www.rockefeller.edu/labheads/chait/. Briefly, proteins were alkylated
in‐gel with 25 mM iodoacetamide, then digested with trypsin (Roche).
Peptides were extracted from the gel slices with a slurry of 25 μg/μl POROS
R2 20 reversed‐phase resin (Applied Biosystems) in 5% formic acid/0.2%
trifluoroacetic acid (TFA) at 4°C for 6 h. The slurry was transferred to C18
Ziptips (Millipore) and washed with 0.1% TFA. Peptides were eluted on a
metal plate with saturated α‐cyano‐4‐hydroxycinnamic acid (4‐HCCA) in
two parts water, one part acetonitrile. MALDI‐MS was performed with a
prOTOF 2000 MALDI‐time‐of‐flight (MALDI‐TOF) mass spectrometer
(Perkin‐Elmer). Tandem mass spectrometry (MS/MS) was performed using
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a vMALDI‐LTQ instrument (Thermo Scientific). The xproteo program
(http://www.xproteo.com) was used for data analysis.

Mass Spectrometric Data Analysis
We have devised a simple method for determining the smooth background
in our mass spectra. This is accomplished by iteratively calculating the
average root mean square deviation (RMSD) in moving windows across the
mass spectrum, excluding the peaks.

Initially, the RMSD is calculated

across the entire spectrum in windows of 1.0 m/z units, with steps of 0.5 m/z
units.

The spectrum is then divided into 30 intervals and the average

RMSD is calculated for each of these intervals. The average RMSD is then
re‐calculated for each of the 30 intervals by excluding all values that deviate
by more than a factor of 1.3 from the average RMSD. This re‐calculation is
then repeated two more times to remove interference from all the peaks.
The final background is the average RMS in each of the 30 intervals after the
fourth iteration, meaning that one value is calculated for each ~100 m/z
units. Masses and signal‐to‐noise ratios (S/N) are then assigned to all peaks.
The

program

for

this

analysis

http://www.rockefeller.edu/labheads/chait/.
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is

available

online

at

Peaks were assigned in the above manner for spectra from samples
that were untreated or treated with HF, with those with a S/N threshold
above 1.1 considered for further analysis. For each peak, the ratio of S/N for
treated versus untreated was computed, and the log of this ratio was scored
as the “phosphopeptide index”. A positive value for the phosphopeptide
index indicates that the peptide is predicted to be phosphorylated, while a
negative

value

indicates

that

the

peptide

is

predicted

to

be

unphosphorylated.

Aurora A preparation and in vitro kinase assay
Xenopus Aurora A coding sequence was amplified by PCR from a full‐
length cDNA clone (Open Biosystems, clone ID#6318106) and cloned into
pET28a vector at BamHI and XhoI sites. Hexahistidine‐tagged Aurora A
was expressed in E. coli and purified as described (Roghi et al., 1998).
Autophosphorylation occurred upon incubation for 30 minutes at 30°C in
kinase buffer (20 mM HEPES, pH 7.7, 150 mM NaCl, 10 mM MgCl2, 1 mM
DTT, 300 μM ATP). The reaction was stopped by boiling in SDS sample
buffer, and reaction products were analyzed by SDS‐PAGE.
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Immunoisolation of Xenopus Chromosome Passenger Complex
150 μL of CSF‐arrested Xenopus laevis egg extract was treated with DMSO
(0.5% v/v) or okadaic acid (0.5 μM) for 30 minutes at 20°C, treated with
nocodazole (10 μg/ml) for 10 minutes at 20°C, then cooled to 4°C for 10 min
before immunoprecipitation of the CPC for 75 min on ice by incubation
with affinity‐purified anti‐xIncenp rabbit polyclonal antibodies crosslinked
to magnetic beads (Dynal). Complexes were washed five times with wash
buffer (20 mM HEPES, pH 7.7, 150 mM KCl, 1 mM MgCl2, 0.1% Triton‐
X100, 1 mM DTT, and phosphatase inhibitor cocktail), transferred to new
tubes, and eluted with 30 μL SDS sample buffer. Immunoprecipitated
complexes were separated by SDS‐PAGE.
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